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Kurzreferat:  
Der Schlaganfall ist in den Industrienationen die dritthäufigste Todesursache und 
eine der führenden Ursachen für eine dauerhafte Behinderung. Seit einiger Zeit 
wird auch der postischämischen immunologischen Reaktion Beachtung 
geschenkt. Nach wie vor wird darüber diskutiert, ob die immunologische 
Reaktion einen positiven oder negativen Einfluss auf die Schwere des 
Schlaganfalls hat. In Experimenten in denen eine Migration von Mikroglia 
(Immunzellen des Gehirns) zum Ort der Ischämie simuliert wurde, konnte 
gezeigt werden, dass Mikroglia in der Lage waren, innerhalb eines bestimmten 
Zeitfensters Nervenzellen vor dem Absterben zu schützen. Hingegen zeigten 
Experimente mit neutrophilen Granulozyten (Rekrutierung aus dem Blut), dass 
diese nach einem Schlaganfall den neuronalen Schaden sogar vergrößern. 
Wurden Mikroglia und neutrophile Granulozyten simultan zu ischämisch 
geschädigten Nervenzellen gegeben, konnte eine Reduktion der Neurotoxizität 
der Granulozyten erzielt werden. In weiteren Experimenten wurde beobachtet, 
dass Mikroglia die potenziell toxischen neutrophilen Granulozyten phagozytieren 
und somit die Nervenzellen indirekt nach einer Ischämie schützen. Daraus lässt 
sich schlussfolgern, dass die postischämische Immunreaktion different auf die 
Schwere des Schlaganfalls Einfluss nimmt und eine antiinflammatorische 
Behandlung aufgrund der auch positiven Eigenschaften der Immunantwort nicht 
unmittelbar zu einer Neuroprotektion führen muss.  
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EINFÜHRUNG UND ZUSAMMENFASSUNG 
Der Schlaganfall ist in den Industrienationen die dritthäufigste Todesursache und 
eine der führenden Ursachen für eine dauerhafte Behinderung. Die Grundlage 
eines Schlaganfalls stellt eine vorübergehende oder dauerhafte 
Durchblutungsstörung von Teilen des Gehirns dar. Dafür ursächlich sind 
Thromboembolien markoangiopathisch veränderter hirnzuführender und 
intrakranieller Gefäße, kardiogene Embolien oder mikroangiopathische 
Veränderungen. Die Behandlungsoptionen des Schlaganfalls sind limitiert. 
Kommt ein Patient mit entsprechenden Schlaganfall-Symptomen, wie z.B. 
akuten Lähmungen, Störungen der Sensibilität oder Sprachstörungen, steht 
innerhalb von 3 - 4,5 Stunden nach Einsetzen der Symptomatik medikamentös 
ausschließlich die Lyse-Therapie zur Rekanalisierung des verschlossenen 
Gefäßes als Behandlungsoption zur Verfügung. Im Folgenden besteht die 
Therapie darin, die relevanten Parameter, wie beispielsweise Blutdruck, 
Blutzucker und Elektrolyte optimal zu führen. Im Anschluss ist eine 
sekundärprophylaktische Therapie anzustreben, die an die Ursache des 
Schlaganfalls angepasst wird, z. B. die orale Antikoagulation bei absoluter 
Arrhythmie oder endovaskuläre Versorgung mit Gefäßdilatation und ggf. 
Implantation einer Gefäßstütze bei Gefäßverengungen. 
Die Optionen in der akuten Schlaganfallbehandlung konnten auch nach 
jahrzehntelanger Forschung nicht erweitert werden. Seit einiger Zeit ist in der 
experimentellen Schlaganfallforschung die Beteiligung des Immunsystems in 
den Fokus gerückt.  
Das hirneigene Immunsystem in Form der Mikroglia wird im Rahmen einer 
zerebralen Ischämie aktiviert. Mikroglia, die in gesundem Gewebe stark 
ramifiziert vorliegen, nehmen nach einer Ischämie eine „aktivierte“ amöboide 
Form an und migrieren zum Ort des ischämischen Schadens (Kreutzberg 1996).  
 
Des Weiteren werden aus dem Blut 6 Stunden nach der Ischämie neutrophile 
Granulozyten und nach 12 - 24 Stunden Monozyten zum Ort des Schadens 
rekrutiert (Prestigiacomo 1999). Die Zellen des adaptiven Immunsystems 
hingegen sind erst nach etwa drei Tagen an der Randzone des ischämischen 
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Schadens zu finden (Liesz 2009). Wie sich die Immunzellen auf die Entwicklung 
des neuronalen Schadens auswirken, ist nach wie vor Gegenstand intensiver 
Diskussionen (del Zoppo 2001; Feuerstein 2001). Im Rahmen meiner 
Promotionsarbeit habe ich mich mit folgenden Fragen auseinandergesetzt:  
 
     1. Welchen Einfluss haben die Zellen des angeborenen Immunsystems  
         (Mikroglia, neutrophile Granulozyten, Monozyten/Makrophagen) auf den  
  neuronalen Schaden nach experimenteller zerebraler Ischämie? 
     2. Wie interagieren diese Immunzellen nach einer Ischämie?  
 
Um diese Fragen adäquat zu bearbeiten, wurde ein postischämisches 
Entzündungsmodell etabliert. Als neuronales Modell kamen organotypische 
hippokampale Schnittkulturen (OHC) mit intakter dreidimensionaler Struktur 
zum Einsatz. Die zerebrale Ischämie wurde durch einen Sauerstoff- und 
Glukoseentzug (OGD) induziert. Um das Einwandern der Mikroglia in das 
geschädigte Areal und die Rekrutierung der neutrophilen Granulozyten sowie 
Monozyten aus dem Blut zu simulieren, wurden diese Zellen nach einer OGD 
auf die hippokampalen Schnittkulturen appliziert. Zur Beurteilung des 
neuronalen Schadens wurde 24 Stunden nach der OGD Propidiumjodid in das 
Kulturmedium gegeben. Propidiumjodid interkaliert in der DNA von Zellen mit 
zerstörter Membranintegrität und zeigt sich bei entsprechender Anregung rot 
fluoreszierend. Im Anschluss wurde die Intensität dieser Rotfärbung in den 
neuronalen Zellbändern des Hippokampus (Cornu Amonis 1-3) gemessen und 
damit der neuronale Zelltod erfasst. Es zeigte sich, dass exogen applizierte 
Mikroglia in einem Zeitfenster von 1 - 4 Stunden nach OGD neuroprotektiv 
wirken (Neumann 2006). Eine Applikation 6 Stunden nach OGD blieb 
wirkungslos. Des Weiteren stellte sich die Protektion durch die Mikroglia 
stimulusabhängig dar, denn eine vorausgehende Stimulation der Mikroglia mit 
einem bakteriellen Agens (Lipopolysaccharide) zeigte, dass sich die 
neuroprotektive Wirkung der Mikroglia aufhob. 
Im Anschluss wurde das Verhalten der Mikroglia zu den Neuronen auf zellulärer 
Ebene untersucht. Dazu wurden hippokampale Schnittkulturen von transgenen 
Mäusen hergestellt, die unter dem Thy-1 Promotor das gelb fluoreszierende 
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Protein exprimieren. Dieses Protein wird selektiv von den Pyramidenzellen im 
Gehirn der Mäuse exprimiert und damit auch in den Pyramidenzellen des Cornu 
Amonis im Hippokampus. Zudem wurden die exogenen Mikroglia mit einem 
roten Farbstoff markiert. Im Anschluss wurden die gefärbten Mikroglia auf den 
organotypischen Schnitt appliziert. Mittels 2-Photonen-Mikroskopie konnte eine 
Ischämie-induzierte Migration der Mikroglia in die Schnittkultur beobachtet 
werden. Unter Kontrollbedingungen zeigte sich keine mikrogliale Migration. 
Darüber hinaus konnte eine Stimulus-(Ischämie)-abhängige Zell-Zell Interaktion 
zwischen Mikroglia und Neuron identifiziert werden (Neumann 2006).  
Im Anschluss wurden die neutrophilen Granulozyten und 
Monozyten/Makrophagen hinsichtlich ihres Einflusses auf den neuronalen 
Schaden nach einer zerebralen Ischämie untersucht. Hier zeigte sich eine starke 
Neurotoxizität bei Applikation von neutrophilen Granulozyten nach der 
Ischämie, wohingegen die Monozyten/Makrophagen weder protektiv noch 
toxisch waren (Neumann 2008). Die Neurotoxizität der neutrophilen 
Granulozyten war nur nach Ischämie präsent. Unter  Kontrollbedingungen 
hingegen waren die neutrophilen Granulozyten nicht toxisch, selbst die sensible 
Langzeitpotenzierung (LTP) wurde  unter Kontrollbedingungen nicht beeinflusst. 
Auch hier erfolgte eine Untersuchung der migratorischen Eigenschaften. 
Neutrophile Granulozyten durchdrangen schon nach kurzer Zeit (ca. 30 Minuten 
– eine Stunde) die gesamte Tiefe des Hirnschnittes (ca. 200 µm). Es fand sich 
hinsichtlich der migratorischen Eigenschaften, anders als bei den Mikroglia, kein 
Unterschied zwischen Kontrollbedingungen und Ischämie. Zusammenfassend 
kann konstatiert werden, dass Mikroglia in den ersten 24 Stunden nach einer 
OGD neuroprotektiv, neutrophile Granulozyten neurotoxisch und 
Monozyten/Makrophagen neutral wirken. 
Im Anschluss wurde das Modell erweitert, indem die Kombination der 
Immunzelltypen auf den neuronalen Schaden untersucht wurde. In diesen 
Experimenten stellte sich überraschenderweise heraus, dass die kombinierte 
Applikation von Mikroglia und neutrophilen Granulozyten die Neurotoxizität der 
Granulozyten signifikant reduziert. Eine Ko-Applikation von 
Monozyten/Makrophagen mit neutrophilen Granulozyten führte zu keiner 
signifikanten Reduzierung der granulozytären  Neurotoxizität. 
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Um dieses Phänomen zu erklären, wurden Mikroglia und neutrophile 
Granulozyten zusammen kultiviert und mittels Zeitraffermikroskopie beobachtet. 
Dabei konnte eine Phagozytose der neutrophilen Granulozyten durch die 
Mikroglia beobachtet werden. Interessanterweise wurden nicht nur apoptotische, 
sondern auch vitale, sich bewegende Granulozyten phagozytiert. Aus der 
Peripherie ist bereits bekannt, dass Makrophagen apoptotische neutrophile 
Granulozyten phagozytieren. Jedoch gibt es keine Hinweise, dass Makrophagen 
vitale neutrophile Granulozyten aufnehmen. In einer Kultur aus Makrophagen 
und neutrophilen Granulozyten konnte keine Phagozytose von vitalen 
Granulozyten beobachtet werden. Das bedeutet, dass die Phagozytose von vitalen 
neutrophilen Granulozyten mikrogliaspezifisch zu sein scheint. Um 
herauszufinden, ob dieser Mechanismus eine indirekte Neuroprotektion darstellt, 
wurden die Experimente mit simultaner Applikation von Mikroglia und 
Granulozyten auf ischämisch geschädigte Hirnschnitte und Gabe von 
Phagozytoseinhibitoren durchgeführt. Die Inhibition von Integrinen- und 
Lektinstrukturen führte zu einer signifikanten Abnahme der phagozytierten 
Granulozyten und hob die durch Mikroglia vermittelte Protektion auf. Daraus ist 
abzuleiten, dass die Phagozytose der neurotoxischen neutrophilen Granulozyten 
durch die Mikroglia einen indirekten neuroprotektiven Mechanismus darstellt 
(siehe Schema). 
Zusammenfassend konnten folgende Erkenntnisse während der Promotionsarbeit 
gewonnen werden: 
1. Mikroglia sind in den ersten 24 - 48 Stunden protektiv, wenn sie 
innerhalb von 4 Stunden am Ort der Ischämie sind. 
2. Monozyten/Makrophagen sind in den ersten 24 - 48 Stunden nach 
Ischämie  weder neuroprotektiv noch neurotoxisch.  
3. Neutrophile Granulozyten sind neurotoxisch nach Ischämie, jedoch nicht 
unter Kontrollbedingungen. 
4. Mikroglia migrieren stimulusabhängig im neuronalem Gewebe zum Ort 
des Schadens. 
5. Neutrophile Granulozyten migrieren stimulus-unabhängig im neuronalen 
Gewebe.  
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6. Die durch Mikroglia vermittelte Protektion ist abhängig von der Art der  
Stimulus (ischämischer Stimulus – Mikroglia protektiv, bakterieller 
Stimulus – Mikroglia nicht protektiv). 
7. Durch eine Ischämie kommt es zu einer Zell-Zell Interaktion zwischen 
Mikroglia und Neuronen. 
8. Mikroglia reduzieren signifikant die neurotoxische Wirkung der 
neutrophilen Granulozyten nach einer Ischämie durch selektive 
Phagozytose von vitalen und proapoptotischen  neutrophilen 
Granulozyten. Diese Phagozytose wird durch Integrin- und 
Lectinstrukturen vermittelt.  
Aus diesen Ergebnissen ist folgendes postischämisches Szenario ableitbar: 
Nach einer zerebralen Ischämie erfolgt eine Aktivierung der lokalen Mikroglia 
und die Attraktion der peripheren Mikroglia zum Ort des ischämischen 
Schadens. Mikroglia sind in der Lage, postischämisch geschädigte Neurone unter 
bestimmten Bedingungen vor weiterem Schaden (vor dem Tod) zu schützen. 
Durch die beobachtete Zell-Zell-Interaktion zwischen Mikroglia und Neuronen 
kann spekuliert werden, dass die Mikroglia die Fähigkeit besitzt, zwischen 
Neuronen zu differenzieren, die möglicherweise noch gerettet werden können 
oder bereits so stark geschädigt sind, dass eine Rettung nicht mehr möglich ist. 
Im Umkehrschluss könnte eine Beschleunigung des Sterbeprozesses eingeleitet 
werden, sodass mit konsekutiver Phagozytose die Freisetzung weiterer 
Entzündungsstimuli verhindert werden kann. Des Weiteren kommt es nach einer 
Ischämie zu einer Infiltration (Extravasion) von neutrophilen Granulozyten in 
das geschädigte Areal. Aufgrund der vorliegenden Ergebnisse kann spekuliert 
werden, dass Mikroglia infiltrierende neutrophile Granulozyten erkennen und 
spezifisch phagozytieren. Damit reduzieren Mikroglia die Neurotoxizität der 
neutrophilen Granulozyten im zerebralen Gewebe. Zusammenfassend können 
den Mikroglia unter experimentellen Bedingungen zwei neuroprotektive 
Eigenschaften zugeschrieben werden: einerseits die direkte Neuroprotektion über 
die Zell-Zell-Interaktion, andererseits die indirekte Neuroprotektion über die 
Phagozytose neurotoxischer neutrophiler Granulozyten. 
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ABSTRACT 
Many neurological insults are accompanied by a marked acute inflammatory reaction, involving 
the activation of microglia. Using a model of exogenous application of fluorescence-labeled BV2 
microglia in pathophysiologically relevant concentrations onto organotypic hippocampal slice 
cultures, we investigated the specific effects of microglia on neuronal damage after ischemic 
injury. Neuronal cell death after oxygen-glucose deprivation (OGD) was determined by 
propidium iodide incorporation and Nissl staining. Migration and interaction with neurons were 
analyzed by time resolved 3-D two-photon microscopy. We show that microglia protect against 
OGD-induced neuronal damage and engage in close physical cell-cell contact with neurons in the 
damaged brain area. Neuroprotection and migration of microglia were not seen with integrin 
regulator CD11a-deficient microglia or HL-60 granulocytes. The induction of migration and 
neuron-microglia interaction deep inside the slice was markedly increased under OGD 
conditions. Lipopolysaccharide-prestimulated microglia failed to provide neuroprotection after 
OGD. Pharmacological interference with microglia function resulted in a reduced 
neuroprotection. Microglia proved to be neuroprotective even when applied up to 4 h after OGD, 
thus defining a “protective time window.” In acute injury such as trauma or stroke, appropriately 
activated microglia may primarily have a neuroprotective role. Anti-inflammatory treatment 
within the protective time window of microglia would therefore be counterintuitive. 
Key words: neuroinflammation • stroke • organotypic cultures • two-photon microscopy • CD11a 
integrin 
bundant evidence exists that an inflammatory reaction is mounted within the central 
nervous system (CNS) following trauma, stroke, and seizure. The inflammation in 
response to acute brain injury is characterized by the infiltration of neutrophils and 
monocytes/macrophages into the respective brain parenchyma; activation of resident microglia; 
and expression of pro-inflammatory cytokines, adhesion molecules, and other inflammatory 
mediators (1, 2). A key issue regarding this well-described inflammation in brain injury is 
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whether this multifactorial reaction is beneficial or detrimental postischemia. Because of its 
complexity, the role of inflammation in acute brain injury remains a controversial subject (3, 4). 
Certain parts of inflammation may contribute to neuronal damage while other components of the 
inflammation may actually be beneficial in the recovery from brain damage. 
To understand the complex process of neuroinflammation and to develop sensible therapeutic 
strategies, we sought to investigate the respective components individually. Since this is almost 
impossible to perform in vivo and the results obtained from dissociated cell cultures are 
obviously limited regarding their in vivo relevance, we chose organotypic interphase slice 
cultures as an experimental model. Organotypic hippocampal slice cultures (OHC) contain the 
different CNS cell types and retain the complex 3-D organization of the nervous tissue (5, 6). 
OHC are thus a useful model system to study the interaction of microglia and neurons (7, 8). 
Most importantly, OHC allowed us to analyze the effects of postischemic microglial 
inflammation excluding factors/cells from the peripheral inflammation such as 
granulocytes/monocytes. 
Under normal conditions, microglia are quiescent and distributed throughout the CNS. One of the 
main characteristics of microglia is their rapid activation in response to a variety of stimuli. 
Several articles have reviewed reactive microglial responses in various pathologies such as 
axonal injury, ischemia, trauma, and neurodegenerative diseases (9–11). Hallmarks of activation 
are proliferation, change of morphology into an amoeboid shape, increased phagocytosis, up-
regulation of MHC class I molecules, and the release of cytokines and growth factors (12, 13) 
In this study, we investigated specific effects on neuronal damage exclusively mediated by 
microglia in OHC after ischemic injury by oxygen-glucose deprivation (OGD). Although OHC 
contain endogenous micoglia, we performed exogenous application of the well characterized and 
widely used microglial cell line BV2 to the OHC. Our rationale for this was to be able to modify 
the microglia before application, increase the microglia numbers to pathophysiologically relevant 
levels, and enhance any microglial effects and ensure they were mediated exclusively by the 
microglia. This method represents a further development of the model previously established by 
our group (8, 14). 
MATERIALS AND METHODS 
OHC  
Hippocampal interphase organotypic cultures were prepared as previously described (5, 15) from 
postnatal day 7–9 Wistar rats (Harlan Winkelmann GmbH, Borchen, Germany). For two-photon 
microscopy experiments, hippocampal slice cultures were prepared from transgenic B6.Cg-TgN 
(Thy1-YFP)16Jrs mice (Jackson, distributed by Charles River, Wilmington, MA), which express 
EYFP at high levels in subsets of central neurons, including the pyramidal cells of the 
hippocampus (16). Hippocampi were dissected and transversely sliced into a 350 µm thickness 
on a McIlwain tissue chopper (The Mickle Laboratory Engineering, Surrey, UK). Slices were 
transferred to Millicell membranes (Millipore, Saint-Quentin-en-Yvelines, France). Cultures were 
maintained at 37°C in 1 ml of the serum-based medium containing 50% MEM-Hanks, 25% 
HBSS, 17 mM HEPES, 5 mM glucose (pH 7.8; Cell Concepts, Umkirch, Germany), 1 mM L-
glutamine (Biochrom, Berlin, Germany), 25% horse serum (HS; Gibco, Eggenstein, Germany) 
and 0.5% Gentamycine (Biochrom) for 2–3 days. Cultures were then maintained in serum-free 
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medium (Neurobasal-A medium with B27 complement, glucose, 5 mM, L-glutamine, 1 mM). 
OHC were selected with propidium iodide (PI, 2 µg/ml; Sigma, St. Louis, MO) before the 
experiment (Fig. 1A). 
OGD 
The inserts with OHC were placed into 1 ml glucose-free medium (GFM) in sterile six-well 
culture plates (TPP). Before use, the GFM had been saturated with 5%CO2/95%N2 for 10 min. 
The six-well culture plates were transferred to a hypoxic chamber (Billups-Rothenberg). Then 
OHC were subjected to the OGD (40 min of OGD in a temperature-controlled hypoxic chamber; 
no glucose medium, N2/CO2 atmosphere). Cultures were kept in regular medium (plus glucose) 
under normoxic conditions. The cultures were analyzed  24 or 48 h after OGD. 
Culture of microglia cell line BV2  
The BV2 microglia were cultured in (D)MEM supplemented with 10% fetal calf serum (FCS) 
(Biochrom), 1% Pen/Strep (Biochrom), and 1% L-glutamine (Biochrom) at a density not 
exceeding 5 × 105cells/ml and maintained in 5% CO2 at 37°C. To apply BV2 microglia, we 
trypsinated cells (trypsin/EDTA) (Biochrom) and then centrifuged them at 500g for 5 min and 
resuspended them in neurobasal medium (Gibco). Cell concentration was determined by counting 
cells in a “Neubauer” hemocytometer, and viability was assessed by trypan blue staining (0.4% 
trypan blue in PBS) (Sigma). BV2 microglia were applied directly onto 10-day-old OHSC in a 
volume of 2 µl neurobasal medium containing 8 × 104 BV2 microglial cells, resulting in 
pathophysiologically relevant microglia numbers in the slice closely resembling those found in 
vivo after global ischemia. Viability of BV2 microglia after application onto the OHC was 
confirmed by prior staining with CMFDA (Molecular Probes, Leiden, The Netherlands). 
BV2 microglia treatment 
To stimulate BV2 microglia before application onto the OHCs, we either exposed them to OGD 
for 40 min or treated them with 50 µg/ml lipopolysaccharide (LPS; Sigma) for 4 h. To block 
protein synthesis in BV2 cells, we pretreated the microglia for 2 h with 10 µM anisomycine 
(Molecular Probes) before application. Microglia were either pretreated with 50 µM minocycline 
for 4 h before the application, or minocycline (25 µM; 50 µM) was applied simultaneously with 
the BV2 microglia at 1 h after OGD. 
Culture and differentiation of cell line HL-60  
Human acute promyelocytic leukemia HL-60 cells were cultured in RPMI-1640 (Biochrom) 
medium supplemented with 10% FCS (Biochrom) and 1% Pen/Strep (Biochrom) at a density up 
to 5 × 105 cells/ml and maintained in 5% CO2 at 37°C. To induce differentiation toward 
granulocytes, we treated HL-60 cells (2×105 cells/ml) with 1 µM all-trans retinoic acid (ATRA) 
for 5 days. Before application, HL-60 cells were counted in a “Neubauer” hemocytometer, and 
viability was assessed by trypan blue staining (0.4% trypan blue in PBS) (Sigma). 
Cloning of an antisense CD11a vector and transfection experiments 
RNA was isolated from BV2 cells (RNeasy Maxi Kit, Qiagen, Valencia, CA) followed by a 
cDNA synthesis (cDNA Synthesis Kit, Clontech, Palo Alto, CA) with random hexamer primer 
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and amplification of the DNA of interest by PCR (MJ Research, Cambridge, MA). The ligation 
of the insert (antisense-CD11a) was made by using the Topo pCR 2.1 vector (Invitrogen, 
Carlsbad, CA) and the T4 DNA Ligase (New England BioLabs, Ipswich, MA). Competent E. 
coli cells (genotype TOP10F') were transformed, and, in addition, the vector was isolated and 
sequenced. After cleavage of the antisense construct, the insert was ligated into the pcDNA3.1 
vector (Invitrogen). Competent E. coli cells (genotype TOP10F') were again transformed, and the 
vector was isolated for cell transfection experiments. Transfections of the pcDNA3.1-control 
vector and the asCD11a vector in BV2 microglial cells were performed by a lipofectin method 
(Rotifect, Carl-Roth). A stable cell line was established by selection with 100 µg/ml zeocin 
during 4 wk. 
Analysis of cell death  
Cell death was evaluated by cellular incorporation of propidium iodide (PI) 24 h and 48 h after 
OGD. Cultures were incubated with PI-containing medium (10 µM) for 2 h at 33°C. Fluorescent 
images were acquired semiautomatized (Nikon motorized stage; LUCIA software) and analyzed 
by densitometry to quantify necrotic cell death (LUCIA Image analysis software). Based on 
transmission light images, the area of analysis was determined excluding the dentate gyrus 
followed by conversion of the fluorescent image into a greyscale image. Background correction 
was performed automatically by a control square (150×150 µm) in the stratum moleculare 
outside the pyramidal cell layer. Damage was detected only in the CA area (CA1-CA2-CA3), 
thus representing neuronal damage. To combine data from individual experiments, the 
densitometric mean value of the respective insult of an individual experiment was set to 100% 
damage. All other data are given in % of insult damage. Nissl-staining was performed 24h after 
OGD. OHC were fixed with 4% PFA for 40 min at room temperature and were then maintained 
in 30% sucrose at 4°C for 2 days. OHC were then cryosectioned to 30 µm thick slices, and Nissl-
staining was performed. 
Two-photon microscopy 
For two-photon microscopy, the microglial cell line was stained with cell tracker orange (CTO, 5 
µM in PBS, 10 min, room temperature; Molecular Probes). At different time points after OGD 
induction, the microglia-brain slice cocultures were subjected to 3-D two-photon microscopy 
using an Olympus BX51WI stage equipped with a XLUMPL ×20, NA 0.95 water dipping lens 
and a multibeam scanhead (LaVision Biotech, Bielefeld, Germany) run at 16 beams with full 
laser power. Image detection was done with a cooled CCD camera (Imager Intense, LaVision, 
Goettingen, Germany). Brain slices were imaged in live modus at 800 and 920 nm wavelength of 
the laser (MaiTai, Spectra physics) using a scanning window of 90 × 150 µm to obtain the upper 
most as well as the lowest possible position within the slice. These positions defined the 
maximum cube of tissue available for imaging. Subsequently, this cube was scanned with a 
resolution in Z of 0.5 µm, first at 920 nm and then at 800 nm wavelength with no filter. The 
emission of EYFP at 800 nm was negligible as was the emission of CTO at 920 nm. Image stacks 
were exported as two independent 8-Bit multilayer TIFF stacks and subsequently reconstructed 
using the AMIRA software package (Berlin, Germany). 
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Statistical analysis  
All data are given as mean ± SD. Statistical analysis was performed by one-way ANOVA 
followed by post hoc comparison (Tukey test). P < 0.05 was considered statistically significant. 
RESULTS 
Microglia protect against OGD-induced neuronal damage 
The focus of this study was to elucidate the role of microglial cells in a model of ischemic injury 
in vitro (see Fig. 1A for experimental setup). Direct application of the microglial cell line BV2 
(up to 8×104 cells/slice in 2 µl) onto otherwise untreated OHC had no effect on neuronal viability 
in the CA area after 24 h (control in Fig. 1B, 1C). For all the following experiments involving 
direct application, 2 µl of 4 × 104 cells/µl was used. Since only ~20% of the applied microglia 
adhered to or invaded into the slice, this exogenous application resulted in in vitro microglia 
(OX-42+) numbers (~1.9×103) that are also found in vivo in the hippocampus after global 
ischemia (~2.3×103). When microglia were transferred directly 24 h before OGD, we observed a 
significant reduction (P<0.001 vs. OGD) of the OGD-induced neuronal damage (Fig. 1B). 
Furthermore, this microglial neuroprotection was also effective when the microglia were added 1 
h or 4 h after OGD (Fig. 1B). At 6 h after OGD, however, the application of microglia was not 
protective anymore (Fig. 1B). Representative fluorescent images for the densitometric 
quantification (Fig. 1B) are shown in Fig. 1C. We could also confirm the neuroprotective effect 
of microglia by Nissl staining. At a ×20 magnification, we observed a lower neuron density and a 
higher number of small shrunken neuronal cell bodies in OGD-treated cultures vs. cultures 
treated with OGD plus microglia (Fig. 1D). Microglia viability was monitored with CMFDA 
vital staining before application. On the slice border, viable (CMFDA+) microglia showed some 
PI uptake under control conditions, which was dramatically increased after OGD (see Fig. 1C; 
arrowhead). 
Granulocytes fail to provide neuroprotection after OGD 
To investigate whether the observed neuroprotective effect was specific for microglia, we 
performed experiments using the granulocyte cell line HL-60. Undifferentiated HL-60 cells had 
no protective effect after OGD and did not alter neuronal viability under basal conditions (Fig. 
2A). In contrast, when HL-60 cells had been differentiated into the granulocyte phenotype by 
treatment with ATRA they caused significant neuronal cell death under basal conditions (Fig. 
2A). However, differentiated HL-60 cells did not exacerbate or ameliorate neuronal cell loss after 
OGD (Fig. 2A), thus confirming the specificity of the neuroprotective microglia effect. 
Representative fluorescent images for the densitometric quantification (Fig. 2A) are shown in Fig. 
2B.These results prompted us to investigate whether a specific interaction occurs between 
microglia and neurons in the slice cultures. 
Microglia migrate into hippocampal slices and engage in close cell-cell contact with neurons 
after OGD 
For the analysis of microglial migration and a possible microglia-neuron interaction in living 
organotypic slice cultures over time, we used 3-D time-resolved two-photon microscopy. 
Microglia were labeled with cell tracker orange (CTO) and then directly applied onto OHC 
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prepared from transgenic B6.Cg-TgN (Thy1-YFP)16Jrs mice. In these transgenic mice, a subset 
of neurons (particularly the CA1 area) is labeled by expression of EYFP. Two-photon 
microscopy was performed at 1 , 7 , and 20 h after OGD and 16 h after microglia application 
under basal conditions (Table 1). Representative images are shown as 3-D reconstruction and a 2-
D collapsed side view of the individual confocal planes (Fig. 3). Under basal conditions, the 
majority of microglia stayed on the surface of the slice and rarely migrated into the slice (Fig. 3A, 
3B). In very few cases, a cellular microglia-neuron interaction was observed on the surface of the 
slice. This interaction is best described as a “capping” of the neuron by the microglia (Fig. 3Aa). 
One hour after OGD, the majority of microglia were still on the slice surface; however, most of 
these microglia showed the “capping” interaction with the first neuronal layer (Fig. 3C, 3D). 
Seven hours after OGD, microglia were detected frequently inside of the slice culture (∼70 μm 
depth). The “capping” interaction could be observed at a majority of microglia on the surface and 
often inside of the slice (70 μm depth; Fig. 3E, 3F). The top neuronal layer (0–30 μm depth) was 
still detectable at this time point (Fig. 3D, 3E). At 20 h after OGD, the majority of microglia had 
migrated into the slice (80 μm depth) and the top neuronal layer was destroyed except for a few 
EYFP+ fragments (Fig. 3G, 3H). We could observe a “capping” interaction of microglia with 
these fragments on the surface, but the majority of “capping” was detected inside of the slice (80 
μm depth; Fig. 3G, 3H). 
Duration of the microglial neuroprotection after OGD 
Next we wanted to assess how long the microglia protective effect lasted. Neuronal cell death in 
the CA area was analyzed by PI uptake densitometry at 24 and 48 h after OGD. Because of 
limitations of our experimental culture system, we were unable to analyze time points later than 
48 h after OGD. We observed a significant protection against OGD-induced neuronal damage at 
24 h and 48 h when the microglia were applied to the slice 1 h after OGD (Fig. 4). 
CD11a-deficient microglia fail to provide neuroprotection 
Based on the two-photon data, we suggested that microglial migration into the slice and 
subsequent interaction with neurons are necessary to provide neuroprotection. To elucidate the 
molecular basis for the microglia-mediated neuroprotective effect after OGD, we generated BV2 
microglia that are unable to express the integrin CD11a. Antisense CD11a-transfected BV2 
[asCD11a] were applied 1 h after OGD directly onto the OHC. We found that asCD11a microglia 
failed to provide neuroprotection after OGD (P<0.001 BV2 [asCD11a] vs. BV2; n=7–18/bar). 
Representative fluorescent images for the densitometric quantification (Fig. 5A) are shown in Fig. 
5B. We could further show by 3-D time-resolved two-photon microscopy that the [asCD11a] 
were still engaging in a “capping” interaction with the neurons on the slice surface 1 h after OGD 
(Fig. 6A). This suggested that the “capping” interaction occurred independently of CD11a 
expression and was not crucial for the neuroprotective effect. The migration of microglia deep 
into the slice culture after OGD was severely inhibited. The [asCD11a] microglia were unable to 
migrate deeper than 50 µm into the injured slice at 1, 7, and 20 h after OGD (Fig. 6B–D) and 
were not colocalized at that depth with neurons, whereas wt-microglia were found colocalized 
with neurons as deep as 80 µm in the slice (Fig. 3H). These data supported our hypothesis that 
CD11a-mediated microglial migration into the injured slice may be necessary for 
neuroprotection. 
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LPS-stimulated microglia fail to provide neuroprotection after OGD 
We further addressed whether preactivation of microglia by OGD or LPS (50 µg, 4 h) had an 
effect on neuroprotection after OGD. Microglia were therefore exposed to OGD or LPS before 
application. Under control conditions, the application of OGD-preactivated microglia had no 
significant neurotoxic effect in the CA1 area (Fig. 7A). LPS-preactivated microglia, however, 
caused a significant (P<0.001 vs. control) neurotoxic effect on untreated control cultures (Fig. 
7A). When OGD-preactivated microglia were applied onto slice cultures 1 h after the slice had 
been subjected to OGD, approximately the same neuroprotective effect as with naïve microglia 
was observed (P<0.01 vs. OGD; Fig. 7A). In contrast, LPS-preactivated microglia failed to 
induce neuroprotection after OGD (Fig. 7A). 
Representative fluorescent images for the densitometric quantification (Fig. 7A) are shown in Fig. 
7B. These data suggested that the observed neuroprotective microglial response required an 
injury-specific stimulus. 
Pharmacological interference with microglial function causes reduced microglia-mediated 
neuroprotection 
We investigated whether the observed microglial neuroprotective effect could be influenced by 
impairment of microglial function. Microglia were added directly onto the slice culture at 1 h 
after OGD. When microglia were pretreated with the protein-synthesis inhibitor anisomycine ( 
2h, 10 µM), we observed a significant reduction (P<0.05 vs. OGD/BV2) in neuroprotection 
compared with untreated microglia (Fig. 8A). This indicates that de novo protein synthesis seems 
to be necessary to achieve the highest neuroprotective microglia effect. The partial 
neuroprotection still observed with anisomycine-treated microglia seems to be independent of de 
novo protein synthesis or could be explained by the reversibility of protein synthesis inhibition by 
anisomycine. When microglia were pretreated with the monocyte inhibitor minocycline (4 h, 50 
µM), we observed a significant reduction (P<0.001 vs. BV2) in neuroprotection compared with 
untreated microglia (Fig. 8A). The simultaneous application of microglia with 25 or 50 µM 
minocycline at 1 h after OGD also caused a significantly lower (P<0.001; P<0.01 vs. OGD/BV2) 
neuroprotection compared with the protection with microglia alone (Fig. 8A). However, there was 
no dose-response effect detected. Representative fluorescent images for the densitometric 
quantification are shown in Fig. 8B. 
DISCUSSION 
The role of inflammation (harmful or beneficial) in the pathogenesis of acute brain injury remains 
a controversial subject (3, 4). To investigate the complex process of neuroinflammation, we 
chose organotypic interphase slice cultures as an experimental model. The aim of this study was 
to investigate effects of microglia on neuronal death in OHC after ischemic injury. Our 
experimental design includes the exogenous application of the microglial cell line BV2 to the 
OHC. We could thus modify microglia before application, reach pathophysiologically relevant 
microglia numbers, and ensure that the observed effects were mediated exclusively by the 
microglia. 
We first found that direct application of up to 8 × 104 BV2 microglia was well tolerated by OHC 
and did not cause any neuronal cell death, demonstrating that under normal conditions the BV2 
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cell line is not neurotoxic in our model. Only ~20% of the applied BV2 microglia adhered to the 
slice and had therefore direct contact to the tissue, while the majority of BV2 microglia 
accumulated on the border of the slice culture. We found that the exogenous application of 8 × 
104 microglia resulted in pathophysiologically relevant microglia numbers inside/on top of the 
slice, resembling closely postischemic in vivo conditions (C. Pforte, personal communication). 
Under insult conditions, we observed that neuronal damage caused by OGD was significantly 
reduced by direct application of microglia onto OHC. The microglia were neuroprotective when 
applied 24 h before and up until 4 h after OGD, but not at 6 h after OGD. This is in line with data 
from our lab (unpublished observations) and others (17) showing that in this model significant 
neuronal cell death appeared at 6–9 h after OGD. Microglia seem to possess a protective time 
window after an ischemic insult. 
We could further show that this neuroprotective effect was still evident until at least 48 h after 
OGD. We found that the observed neuroprotection was specific for microglia since the human 
granulocyte cell line HL-60 had no significant effect on neuronal damage after OGD. Under basal 
conditions, differentiated HL-60 granulocytes caused a significant increase in neuron death and 
there was also a tendency toward worsening injury-induced neuron death by HL-60 granulocytes. 
These results are in line with recent data showing the neurotoxic potential of granulocytes (18, 
19) 
These results indicated that the microglial neuroprotection might be based on a specific 
interaction between microglia and neurons in the slice cultures. Previous studies showed that 
exogenously applied microglia migrated into slice cultures under normal and NMDA-excitotoxic 
conditions (20, 21). We used a novel two-photon microscopy approach to study the interaction of 
fluorescence-labeled microglia with fluorescence-labeled neurons in living brain tissue of 
transgenic animals. We show for the first time that microglia migrated into the slice and engaged 
in close cell-cell contact with neurons (“capping”). Furthermore, the induction of migration and 
neuron-microglia interaction deep inside the slice were dramatically increased by OGD. Based on 
our 3-D reconstruction images, we propose the following “mode of action” for the microglia-
mediated protection. Immediately after OGD, microglia are activated by injured neurons and 
engage in close cell-cell contact with the first neuronal layer (“capping”). Since these neurons die 
later on, this capping could ensure the early recognition and fast phagocytic removal of 
dying/dead neurons. This mechanism would provide protection for the neurons in the deeper 
layers of the slice by minimizing the exposure time and dose of these cells to cytotoxic cell 
contents/debris released from dead/dying neurons. At later time points, we detected microglia 
that had migrated ~80 µm into the slice. These microglia could provide trophic support by the 
release of growth factors to improve the survival of the neurons in the deeper layers of the slice. 
The close proximity of injured neurons to microglia may also facilitate the targeted delivery of 
neurotrophic growth factors such as BDNF, GDNF, NGF, or TGF-β (12, 22). 
Here the question arises: which mechanism directs microglial cells to the region of injury 
neurons, facilitates their migration, and keeps them in close cell-cell contact with the damaged 
neurons? Since migration and adhesion of microglial cells is mediated at least partially by 
expression of the integrin CD11a (8), we tested the possibility that this molecule is also involved 
in the observed neuroprotective action. Indeed, we found that microglial cells with down-
regulated CD11a expression failed to protect neurons after ischemic damage and showed that 
CD11a expression and therefore assembly of LFA-1 is involved in the protective innate 
immunity provided by invading microglial cells, by enabling migration (8). Direct microglia-
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neuron cell-cell contact (23) could also play a role in the deeper layers of the slice; however, the 
“capping” interaction between microglia and neurons on the slice surface was also observed in 
the absence of CD11a expression and neuroprotection. 
We could also show that LPS-prestimulated microglia in contrast to naïve and OGD-preactivated 
microglia failed to provide neuroprotection after OGD. This suggests that microglia are 
differentially activated by injury-specific stimuli and can in turn only be beneficial in the 
corresponding injury model. Consequently, it is not surprising that LPS activation of microglia 
did not result in neuroprotection but instead in an exacerbation of cerebral ischemic injury (24). 
A pharmacologically induced impairment of microglial function resulted in a reduced 
neuroprotective effect after OGD. This was demonstrated by pretreatment of microglia with the 
protein synthesis inhibitor anisomycine or the anti-inflammatory tetracycline derivate 
minocycline, which inhibits the p38 MAPK pathway. In contrast to our data, minocycline has 
been shown to be neuroprotective against excitotoxicity and brain ischemia (25, 26). In these 
studies, minocycline could exert effects not exclusively on microglia but also on all other cell 
types (e.g., neurons and/or astrocytes). Due to our experimental design (pretreatment of microglia 
with minocycline before exogenous application), we could exclude side effects of the respective 
compounds on cell types other than microglia. 
The demonstrated neuroprotective effect of microglia seems to be in sharp contradiction to 
previous studies suggesting that activation of microglia contributes to ischemic and excitotoxic 
cell death (25, 27–31). However, much of the information on the neurotoxic properties of 
activated microglia is derived from in vitro studies using monolayer dissociated cell cultures (26, 
32–34). As mentioned previously, individual investigation of specific components of 
neuroinflammation after ischemia is almost impossible using in vivo studies. Often, conclusions 
are drawn from in vivo studies about the role of microglia without differentiation between 
microglia, macrophages, and neutrophils and their individual effects and reactions to various 
treatments. Moreover, several lines of evidence suggesting that postischemic inflammation has 
deleterious effects on ischemic injury focus on the reduction of leukocyte infiltration as a 
therapeutic target and not on microglia inhibition (35, 36). As a consequence of this 
generalization, microglia suffer from a bad reputation as contributors of cell death in ischemic 
and neurodegenerative disorders. On the other hand, considerable evidence shows that microglial 
activation after acute CNS injury is triggered by injured/dying neurons and results in reduction of 
neuronal damage and tissue repair (37–46). In OHC, excitotoxic neuronal damage was increased 
by pharmacological depletion of microglia (47) whereas NMDA neurotoxicity was decreased by 
microglia overexpressing the macrophage colony-stimulating factor receptor (48). Nimmerjahn et 
al. showed that microglia interact with endothelial cells to shield a focal blood-brain barrier 
disruption, providing another example of how microglia protect the brain environment by direct 
cell interaction (49). 
In summary, our results demonstrate for the first time that microglia in pathophysiologically 
relevant numbers protect against OGD-induced neuronal damage and engage in close contact 
with neurons in living brain tissue. There is also evidence for a protective time window of 
microglia after ischemia which should not be the target of anti-inflammatory intervention. There 
is no doubt that microglia can secrete potentially neurotoxic substances, but also factors to 
promote neuronal survival and tissue repair (39, 50). It seems likely that the type and degree of 
injury (e.g., stroke, acute ischemia, Alzheimer’s disease, and chronic neurodegeneration) activate 
microglia differently toward performing neuroprotective or neurodestructive effects. 
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Table 1 
 
Microglia migration and interaction with neurons in organotypic hippocampal slice culturea 
 
 Microglia Neurons (depth) Interaction “Capping” 
 Surface Inside  Surface Inside 
Basal 16 h ++ (–) 
 
0–30 µm: 1st layer (+) – 
OGD 1 h ++ (+) 
30 µm 
0–30 µm: 1st layer ++ – 
 
OGD 7 h  ++ ++ 
70 µm 
0–30 µm: 1st layer ++ ++ 
65µm 
OGD 20 h + ++ 
80–100 µm 
0–30 µm: gone, fragments 
>30 µm: present 
+ 
fragments 
++ 
80 µm 
 
aMicroglia were labeled with CTO (red) and then directly applied onto organotypic hippocampal cultures prepared from transgenic B6.Cg-TgN 
(Thy1-YFP)16Jrs mice. Two-photon microscopy live image acquisition was performed at indicated timepoints (–, not detected; (+), rarely detected; 
+, frequently detected; ++, majority of cells). 
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Fig. 1 
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Fig. 1 (cont) 
 
              
 
 
Figure 1. Protection against oxygen-glucose deprivation (OGD)-induced neuronal damage by microglia directly applied 
onto hippocampal slice cultures. A) BV2 microglia were applied onto the OHCs 24 h before or 1, 4, or 6 h after OGD. B) 
Quantification of neuronal death in cornu amonis (CA) by propidium iodide (PI) incorporation was determined after 24 h 
(***P<0.001 vs. OGD; n=6–8/bar). C) Representative PI fluorescent images showing neuronal death in CA. Arrowhead 
indicates PI-positive microglia on the slice border. D) Nissl staining was performed to confirm the PI data. The white box 
in the left panels (×5) indicates the position of the right panels (×20) in the CA1 area. 
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Fig. 2 
 
         
 
Figure 2. HL-60 neutrophils fail to provide neuroprotection after OGD-induced damage. Undifferentiated HL-60 cells or 
ATRA-differentiated HL-60 cells were applied directly onto untreated (basal) hippocampal slice cultures 1 h after OGD. 
Quantification of neuronal death in the CA region by PI incorporation was determined after 24 h (***P<0.001 control vs. 
basal + HL-60 [ATRA]; n=6–7/bar). A) Brackets indicate the differentiation pretreatment with ATRA (all-trans-retinoic 
acid). B) Representative PI fluorescent images showing neuronal death in CA 1-3. 
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Fig. 3 
 
                     
Figure 3. Migration of microglia into organotypic hippocampal cultures and “capping” interaction with neurons under 
normal and ischemic conditions. BV2 microglia were labeled with CTO (red) and then directly applied onto organotypic 
hippocampal cultures (OHCs) prepared from transgenic B6.Cg-TgN (Thy1-YFP)16Jrs mice (neurons: green). At indicated 
time points (Basal+ 16 h, OGD+ 1 h, 7 h, 20 h) Z-stacks were performed from living OHCs using two-photon microscopy. 
Images show 3-D reconstruction (A, Aa, C, E, G) and 2-D collapsed side view of the individual confocal planes (B, D, E, 
F). Aa) Images show a 180° view of a “capping” interaction between a neuron (green) and a BV2 microglia (red). C, E, G) 
“Capping” is marked by arrows. D, F, H) “Capping” is marked by arrows showing double labeling (yellow). White 
brackets indicate the “first neuronal layer,” and white dashed lines indicate “depth in the slice.” H) Asterisks indicate 
neuronal fragments. 
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Fig. 4 
 
 
 
Figure 4. Duration of neuronal protection provided by microglia. Determination of neuronal death after 24 h and 48 h. 
BV-2 microglia were applied directly to the organotypic hippocampal cultures (OHCs) 1 h after oxygen-glucose 
deprivation (OGD). Quantification of neuronal death in CA over 48 h was determined by propidium iodide incorporation 
(***P<0.001 vs. OGD; n=6–8/bar). 
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Fig. 5 
 
 
 
Figure 5. Antisense CD11a-transfected BV2 fail to provide neuroprotection after OGD-induced damage. Antisense 
CD11a-transfected BV-2 [asCD11a] were applied directly onto untreated (basal) hippocampal slice cultures 1 h after OGD. 
A) Quantification of neuronal death in the CA region by PI incorporation was determined after 24 h (***P<0.001 BV-2 
[asCD11a] vs. BV-2; n=7–18/bar). VC = vector control. B) Representative PI fluorescent images showing neuronal death 
in CA 1-3. 
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Fig. 6 
 
                                              
Figure 6. Antisense CD11a-transfected BV2 fail to migrate into organotypic slice cultures after OGD-induced damage. 
Antisense CD11a-transfected BV-2 [asCD11a] were labeled with CTO (red) and then directly applied onto organotypic 
hippocampal cultures (OHCs). At indicated time points (OGD+ 1 h, 7 h, 20 h), Z-stacks were performed from living OHCs 
using two-photon microscopy. Images show 3-D reconstruction (A) and 2-D collapsed side view of the individual confocal 
planes (B, C, D). A) “Capping” is marked by arrows. B, C) “Capping is marked by arrows showing double labeling 
(yellow). B, C, D) White brackets indicate the “first neuronal layer,” and white dashed lines indicate “depth in the slice.” 
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Fig. 7 
 
      
 
Figure 7. LPS-stimulated microglia fail to provide neuroprotection after oxygen-glucose deprivation (OGD). Microglia 
were preactivated by LPS (4 h; 50 µg/ml) or OGC (40 min) before they were applied onto organotypical hippocampal 
cultures (OHCs). Application of differently activated BV2 microglia was performed onto OHCs under basal conditions or 
after exposition of OHCs to OGC. A) Quantification of neuronal death in CA determined by propidium iodide 
(***P<0.001; **P<0.01; n=6–8/bar). B) Representative PI fluorescent images showing neuronal death in CA. 
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Fig. 8 
 
    
 
Figure 8. Anisomycine and minocycline reduce BV2 microglia-mediated neuroprotection. To block protein synthesis, we 
pretreated microglia with 10 µM anisomycine for 2 h before application onto organotypic hippocampal cultures (OHCs). 
To inhibit the p38-MAPK signal pathway, either microglia were pretreated with 50 µM minocycline for 4 h before the 
application or minocycline (25 µM; 50 µM) was applied simultaneously with the BV2 microglia at 1 h after oxygen-
glucose deprivation (OGD). Brackets indicate the respective pretreatment. A) Quantification of neuronal death in CA was 
performed by densitometric anaylsis of PI incorporation (***P<0.001; **P<0.01; *P<0.05 vs. OGD/BV2; n=6–8/bar). B) 
Representative PI fluorescent images showing neuronal death in CA. 
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Microglia Cells Protect Neurons by Direct Engulfment of
Invading Neutrophil Granulocytes: A NewMechanism of
CNS Immune Privilege
Jens Neumann,1 Steven Sauerzweig,1 Raik Ro¨nicke,1 Frank Gunzer,3 Klaus Dinkel,1 Oliver Ullrich,2,4
Matthias Gunzer,2,5* and Klaus G. Reymann1,6*
1Leibniz Institute for Neurobiology, Project Group Neuropharmacology, and 2Institute of Immunology, Otto von Guericke University Magdeburg, 39118
Magdeburg, Germany, 3German University in Cairo, 11771 Cairo, Egypt, 4Institute of Anatomy, Faculty of Medicine, University Zurich, CH-8057 Zurich,
Switzerland, 5Helmholtz Centre for Infection Research, Junior Research Group Immunodynamics, 38124 Braunschweig, Germany, and 6Institute for
Applied Neuroscience (Institute fu¨r Angewandte Neurowissenschaften FAN gGmbH), 39120 Magdeburg, Germany
Microglial cells maintain the immunological integrity of the healthy brain and can exert protection from traumatic injury. During
ischemic tissue damage such as stroke, peripheral immune cells acutely infiltrate the brain and may exacerbate neurodegeneration.
Whether and how microglia can protect from this insult is unknown. Polymorphonuclear neutrophils (PMNs) are a prominent immu-
nologic infiltrate of ischemic lesions in vivo. Here, we show in organotypic brain slices that externally applied invading PMNsmassively
enhance ischemic neurotoxicity. This, however, is counteracted by additional application of microglia. Time-lapse imaging shows that
microglia exert protection by rapid engulfment of apoptotic, but, strikingly, also viable, motile PMNs in cell culture and within brain
slices. PMN engulfment is mediated by integrin- and lectin-based recognition. Interference with this process using RGDS peptides and
N-acteyl-glucosamineblocks engulfmentofPMNsandcompletely abrogates theneuroprotective functionofmicroglia. Thus, engulfment
of invading PMNs by microglia may represent an entirely newmechanism of CNS immune privilege.
Key words: neuroinflammation; stroke; microglia; polymorphonuclear granulocytes; PMN; phagocytosis; time-lapse imaging
Introduction
Abundant evidence exists that an inflammatory response is
mounted within the CNS after cerebral ischemia. Postischemic
inflammation comprises the infiltration of polymorphonuclear
granulocytes andmonocytes/macrophages into the injured brain
parenchyma, activation of microglia, and expression of proin-
flammatory cytokines, adhesionmolecules, and other inflamma-
tory mediators (Feuerstein et al., 1998; Dirnagl et al., 1999). De-
spite these well described inflammatory events after ischemia, the
main impact of postischemic inflammation (beneficial or detri-
mental) is controversially discussed (del Zoppo et al., 2001;
Feuerstein and Wang, 2001).
There is striking evidence that the infiltration of activated
polymorphonuclear neutrophils (PMNs) (Kochanek and Hal-
lenbeck, 1992; Jean et al., 1998; Prestigiacomo et al., 1999) into
the injured parenchyma and the activation of microglia (Banati
and Graeber, 1994; Kreutzberg, 1996; Minghetti and Levi, 1998)
are playing an important role in the pathology of cerebral
ischemia.
It is suggested that activated PMNs contribute to tissue dam-
age by the release of oxygen radicals, proteases, and proinflam-
matory cytokines like TNF (tumor necrosis factor) (Barone et
al., 1991; Jordan et al., 1999). As evidence, experimental strategies
by avoiding PMN infiltration into the injured parenchyma are
neuroprotective (Heinel et al., 1994; Beray-Berthat et al., 2003b;
Miljkovic-Lolic et al., 2003). However, other studies failed to
provide clear evidence of a cause–effect of PMN contribution to
neuronal damage after ischemia (Hayward et al., 1996; Fass-
bender et al., 2002; Beray-Berthat et al., 2003a;Harris et al., 2005).
Similarly controversial findings exist regarding the role of mi-
croglia after ischemia. Several studies demonstrated the neuro-
toxic properties of activated microglia after ischemic or excito-
toxic damage (Giulian et al., 1993; Kim andKo, 1998; Rogove and
Tsirka, 1998; Yrjanheikki et al., 1999), whereas considerable evi-
dence shows that microglia triggered by injured/dying neurons
mediate a reduction of neuronal damage and induction of tissue
repair (Morioka et al., 1991; Rapalino et al., 1998; Streit, 2002;
Kohl et al., 2003; Kitamura et al., 2004; Shaked et al., 2005; Ha-
yashi et al., 2006; Lalancette-Hebert et al., 2007).
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Considering these controversial findings on the role of PMNs
and microglia during transient ischemia, strikingly few studies
have evaluated the direct effect of these immune cells on neuronal
survival/damage (Dinkel et al., 2004; Mitrasinovic et al., 2005).
Despite that, although the combined recruitment of both cell
types to tissue sites affected by cerebral ischemia is well estab-
lished, a potential direct interaction of both immune cell types
has not been investigated in depth. Two recent studies demon-
strated a possible microglia–PMN interaction. By histology, mi-
croglia with engulfed PMNs were observed in zones of focal ce-
rebral ischemia in vivo (Denes et al., 2007; Weston et al., 2007).
To better understand the complexity of cellular inflammation
after experimental ischemia, we investigated the individual im-
pact of PMNs, microglia, and macrophages on neuronal survival
after ischemia and studied how these cells interact during the
inflammatory response. To achieve this, we used an inflamma-
tion model that comprises oxygen–glucose deprivation (OGD)
in organotypic hippocampal slice cultures (OHCs) as ischemic
model and the application of immune cells onto the OHCs as
simulation of the postischemic immune cell infiltration into the
injured parenchyma.
Materials andMethods
Induction of focal cerebral ischemia by middle cerebral artery
occlusion with endothelin-1
Focal cerebral ischemia was induced by occlusion of the left middle ce-
rebral artery (MCA) via intracerebral microinjection of endothelin-1
(ET-1), following Sharkey andButcher (1995) andBaldauf andReymann
(2005). Briefly, anesthesia was induced with halothane in a mixture of
nitrous oxide and oxygen (50:50), and maintained with 2–3% halothane
(Sigma-Aldrich) via a rat anesthetic mask (Sto¨lting). A 29 gauge cannula
was inserted through the brain close to the MCA. Ischemia was induced
by injection of 376 pmol of ET-1 (Sigma-Aldrich). The animals were
killed by an overdose of chloral hydrate (Sigma-Aldrich) after 1 d. Frozen
brains were cut coronally and 30 m slices were taken for additional
staining.
Organotypic hippocampal slice cultures
Hippocampal interface organotypic cultures were prepared as previously
described (Stoppini et al., 1991; Neumann et al., 2006) from postnatal
day 7–9Wistar rats (HarlanWinkelmann). For two-photon microscopy
experiments, hippocampal slice cultures were prepared from transgenic
B6.Cg-TgN(Thy1-YFP)16Jrs mice (The Jackson Laboratory; distributed
by Charles River), which express enhanced yellow fluorescent protein
(EYFP) at high levels in subsets of central neurons, including the pyra-
midal cells of the hippocampus (Feng et al., 2000). Hippocampi were
dissected and transversely sliced at 350 m thickness with a McIlwain
tissue chopper (The Mickle Laboratory Engineering). Slices were trans-
ferred to Millicell membranes (Millipore). Cultures were maintained at
37°C in 1 ml of serum-based medium containing 50% MEM-Hanks,
25% HBSS, 17 mM HEPES, 5 mM glucose, pH 7.8 (Cell Concepts), 1 mM
L-glutamine (Biochrom), 25% horse serum (Invitrogen), and 0.5% gen-
tamycin (Biochrom) for 2–3 d. Cultures were thenmaintained in serum-
free medium (Neurobasal A medium with B27 complement, 5 mM glu-
cose, 1 mM L-glutamine). The OHCs were selected by adding a nontoxic
concentration of propidium iodide (PI) (2 g/ml; Sigma-Aldrich) 12 h
before the experimental start. PI-negative slices were considered to be
healthy, and only these slices were used for the experiments.
Isolation of polymorphonuclear granulocytes (PMNs)
Human PMNs were prepared from venous blood (8 ml) of healthy vol-
unteers. The rat PMNs were prepared from blood of Wistar rats (Harlan
Winkelmann). Briefly, anesthesia in rats was induced with chloral hy-
drate followed by opening the thorax. The left ventricle of the heart has
been punctured under direct visualization, and 10–12 ml of blood was
obtained per rat. The blood was collected in a vacutainer containing
EDTA (BD Biosciences). The anticoagulated whole blood was carefully
layered over 5 ml of the density gradient Polymorphprep (Axis-Shield).
Samples were centrifuged for 35min at 500 g. After centrifugation, two
leukocyte bands were visible. The top band contained the fraction of
mononuclear cells, and the lower band contained the fraction of PMNs.
The fraction of PMNs was collected by pipetting. PMNs were washed
with PBS. Contaminating erythrocytes were removed by hypotonic lyses
in plainH2O for 20 s followed by addition of the same volume of 2 PBS
to restore osmolarity. PMNs were pelleted and resuspended in DMEM/
10% fetal calf serum (FCS). Cell yield (1.5  107 cells per preparation)
was determined by counting cells in a “Neubauer” hemocytometer, and
viability (99%) was assessed by trypan blue staining (0.4% trypan blue
in PBS; Sigma-Aldrich). PMN preparations contained 95% neutro-
phils assessed by hematoxylin/eosin staining on smears, whereas only a
few basophil and eosinophil granulocytes could be detected. No mono-
cytes or lymphocytes contaminated the preparation.
Isolation of rat primary microglia
Primarymicroglia cultures were prepared from postnatal day 2–3Wistar
rats (Harlan Winkelmann) and cultured in DMEM supplemented with
10% FCS (Biochrom), 1% Pen/Strep (Biochrom), and 1% L-glutamine
(Biochrom). After 6 or 7 d of primary cultivation, microglia cells were
separated from other cell types by shaking, placed in a 25 ml flask (TPP)
at a density not exceeding 5 105 cells/ml andmaintained in 5%CO2 at
37°C for 2 d. Cultures consisted of 95%microglia cells as determined by
staining with Alexa 568-conjugated Griffonia simplicifolia isolectin B4
(Invitrogen).
Culture of macrophage cell line RAW 264.7
The macrophage cell line RAW 264.7 was cultured in DMEM supple-
mented with 10% FCS (Biochrom), 1% Pen/Strep (Biochrom), and 1%
L-glutamine (Biochrom) at a density not exceeding 1 106 cells/ml and
maintained in 5% CO2 at 37°C.
Application of cells onto OHCs
Isolated primary microglia or macrophages were trypsinated (trypsin/
EDTA; Biochrom), centrifuged at 500  g for 2 min, and finally resus-
pended in Neurobasal medium (Invitrogen). PMNs were freshly pre-
pared shortly before the experimental start. PMNswere also resuspended
in Neurobasal medium. The cells were applied directly onto 10-d-old
OHCs in a volume of 1 l of Neurobasal medium containing 8  104
microglia, macrophages, or 1 105 PMNs. Viability of microglia, mac-
rophages, and PMNs after application onto the OHC was confirmed in
initial experiments by previous staining with 5-chloromethylfluorescein
diacetate (CMFDA) (Invitrogen) and by time-lapse microscopy of these
cells (data not shown). As indicated, OHCs were fixed with 4% parafor-
maldehyde (PFA) and mounted with 3:1 PBS/glycerol. OHCs were then
further analyzed with the indicated microscopy approach.
Oxygen–glucose deprivation
The membrane inserts carrying up to three OHCs were placed into 1 ml
of glucose-free medium in sterile six-well culture plates (TPP) that had
previously been saturated with 5% CO2/95% N2 for 10 min. Then OHC
were subjected to the OGD [40min of OGD in a temperature-controlled
hypoxic chamber (Billups-Rothenberg); no glucose medium; N2/CO2
atmosphere] before retransfer into normal conditions. Control cultures
were kept in regular medium (plus glucose) under normoxic conditions.
The cultures were analyzed as indicated by individual experiments 24 or
48 h after OGD.
Analysis of cell death
Cell death was evaluated by cellular incorporation of PI at 24 or 48 h after
OGD. Cultures were incubated with PI-containing medium (10 M) for
2 h at 33°C. Fluorescent images were acquired in a semiautomatic man-
ner (Nikon motorized stage; LUCIA software) and analyzed by densi-
tometry to quantify necrotic cell death (LUCIA Image analysis software).
Based on transmission light images, the area of analysis was determined
such that only the CA area (CA1–3) was analyzed, whereas the dentate
gyrus was excluded. Background correction was performed automati-
cally by a control square (150  150 m) in the stratum moleculare
outside the pyramidal cell layer. To combine data from individual exper-
iments, the densitometric mean value of the respective insult of an indi-
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vidual experiment was set to the value of 1 and given as relative fluores-
cence intensity. All other data are given as relative fluorescence intensity
of the insult damage.
Electrophysiology
Wistar rats (25 d old) (HarlanWinkelmann) were killed by a blow on the
neck. After decapitation, the brain was quickly removed and placed into
ice-cold artificial CSF (ACSF) having the following composition (inmM):
124NaCl, 4.9 KCl, 1.3MgSO4, 2.5 CaCl2, 1.2 KH2PO4, 25.6 NaHCO3, 10
D-glucose, saturated with 95% O2 and 5% CO2, pH 7.4. Transverse hip-
pocampal slices (350m thickness) with adjacent subicular and entorhi-
nal cortices were prepared using a vibratome (microm HM 650V). The
slices were placed on Millicell membranes in a six-well cluster dish
(Sigma-Aldrich) with 1 ml of high K culture media [25% horse serum
(Invitrogen); 40%Eagle’s Basal EssentialMedia (BME) (Sigma-Aldrich);
25% Earle’s balanced salt solution (Sigma-Aldrich); 10% 250 mM Na-
HEPES in BME, pH 7.3; 0.5 mM L-glutamine (Sigma-Aldrich); 28 mM
glucose, pH 7.32]. One hour after preparation, 2 l of high K culture
media containing 4 105 PMNs and 2 l of cell-free media for control
experiments, respectively, were applied on top of the slices and incubated
overnight at 33°C in a humidified carbogen atmosphere (95% O2/5%
CO2). Then, the slices were transferred into an interface-type recording
chamber saturated with carbogen at 33 1°C and constantly superfused
with ACSF. Synaptic responses were elicited by stimulation of the Schaf-
fer collateral–commissural fibers in the stratum radiatum of the CA1
region using lacquer-coated stainless-steel stimulating electrodes. Glass
electrodes (filledwithACSF, 1–4M) were placed in the apical dendritic
layer to record field EPSPs (fEPSPs). The initial slope of the fEPSP was
used as a measure of this potential. The stimulus strength of the test
pulses was adjusted to 30% of the EPSP maximum. During baseline
recording, three single stimuli (10 s interval) were averaged every 5 min.
After tetanization, recordings were taken as indicated in Figure 1C. Once
a stable baseline had been established, long-term potentiation was in-
duced by application of four times two-paired pulses in intervals of 200
ms (theta burst). The interval between the paired pulses was 10 ms, and
the width of a single pulse was 0.2 ms.
Two-photon microscopy
For two-photon microscopy, PMNs were labeled with Cell Tracker
Orange [5-(and-6)-(((4-chloromethyl)benzoyl)-amino)tetramethyl-
rhodamine (CMTMR)] (7.5 M in PBS, 10 min, room temperature;
Invitrogen). At different time points after OGD induction, the OHCs
were fixed with 4% PFA, subsequently mounted and subjected to three-
dimensional two-photon microscopy. In other experiments, viable
OHCs were analyzed. PMNs were labeled with CMFDA and microglia
withCMTMRandboth applied ontoOHCs. Twohours after experimen-
tal start, the OHCs were placed in a custom-built chamber supplied with
37°C and 5% CO2 directly under the microscope. The two-photon mi-
croscope setup was used exactly as previously described (Neumann et al.,
2006). OHCs prepared from transgenic B6.Cg-TgN(Thy1-YFP)16Jrs
mice (Feng et al., 2000) were imaged in a modus at 800 and 920 nm
wavelength of the laser (MaiTai; Spectra Physics) using a scanning win-
dow of 90  150 m size. With a resolution in Z of 1 m, the entire
thickness of the OHC was scanned, first at 920 nm and then at 800 nm
wavelength with no filter. The emission of EYFP at 800 nmwas negligible
as was the emission of Cell Tracker Orange at 920 nm. Image stacks were
exported as two independent 16-bit multilayer TIFF stacks and subse-
quently reconstructed using the Volocity software package
(Improvision).
Confocal microscopy
Cultures were examined with a confocal microscope equipped with a
40magnification Plan Neofluar 0.75 objective, an argon laser emitting
at 488 nm, and a helium/neon laser emitting at 543 nm. Multitracking
was used to avoid cross talk between channels. Imageswere analyzedwith
Carl Zeiss software (Pascal; Carl Zeiss).
Time-lapse video microscopy
The cellular dynamics of PMN–microglia interaction were investigated
using OHCs or an in vitro PMN–microglia coculture.
Time-lapse microscopy of OHCs. Fluorescently labeled PMNs
[7-amino-4-chloromethylcoumarin(CMAC)] andmicroglia (CMTMR)
were applied onto OHCs. Two hours after start of the experiment, the
OHCs were placed in a custom-made chamber (Incubator S-M; Pecon)
adjusted to 37°C and 5% CO2 (CTI-Controller 3700 digital; Tempcon-
trol 37–2 digital; Pecon).
Time-lapse microscopy of PMN–microglia coculture. Primary microglia
were cultured onto Matrigel-coated surfaces in a 12-well plate (Falcon;
BD Biosciences Discovery Labware). Matrigel basement membrane ma-
trix (BD Biosciences), containing laminin as a major component, was
diluted in ice-cold DMEM (ratio, 1:20) and polymerized at 37°C for 30
min. Thereafter, 2  105 microglia/well were placed and recovered for
1 d. Freshly prepared human PMNs were applied to the primary micro-
glia culture. If indicated, PMNs were CMFDA labeled prior to applica-
tion. Thirty minutes after the experimental start, the coculture was
placed into the chamber as described above. The time-lapse microscope
was based on an Axiovert 200M (Carl Zeiss) stage equipped with a 10,
numerical aperture (NA) 0.3 lens or a 32, NA 0.5 lens (Carl Zeiss) and
a CCD camera (Axiocam MRm; Carl Zeiss). Images were recorded at
defined time intervals. The datawere subsequently analyzedwith theCarl
Zeiss software (AxioVs40 V4.5).
Statistical analysis
All data are given as mean SEM. Statistical analysis was performed by
one-way ANOVA followed by post hoc comparison (Tukey’s test). A
value of p 0.05 was considered statistically significant.
Results
PMNs infiltrate the brain parenchyma after focal ischemia
Given the heterogeneity of the data concerning the relevance of
peripheral immune cells for ischemia-induced neuronal damage,
we first wanted to investigate which type of peripheral immune
cell was initially recruited into the injured brain parenchyma after
transient ischemia. To this end, endothelin was injected directly
above the MCA. Endothelin as vasoconstrictor occluded the
MCA for 30 min. We found that, 1 d after injection,
endothelin-mediated transient focal ischemia induced a cellular
infiltrate that was mainly composed of PMNs as detectable from
the characteristic lobulated nuclei of infiltrating cells in immu-
nohistological sections of the damaged area (Fig. 1A). We found
no marked infiltration with other peripheral immune cells such
asmacrophages or lymphocytes. Thus, the acute cellular infiltrate
of the ischemia-injured brain in vivo was dominated by PMNs,
suggesting a prominent role of this immune cell type for the
additional development of neuronal damage.
Application of human PMNs onto organotypic hippocampal
cultures does not influence neuronal survival
Following the results of the in vivo ischemia-induced recruitment
of PMNs (Fig. 1A), one goal of this study was to clarify the role of
PMNs for the development of neuronal viability. To this end, we
chose a well established model of ischemic injury in situ using
OHCs that maintain many characteristics of true brain–paren-
chyma, especially the complex three-dimensional structure of
neuronal circuits, yet allow for precise control of cellular or hu-
moral factors impacting on neuronal viability as described previ-
ously (Neumann et al., 2006). The first step was to evaluate
whether PMNs as such had a detrimental effect on neuronal via-
bility in healthy OHCs. Because of the very limited availability of
primary rat PMNs, we chose to use human PMNs throughout
this study and performed only key experiments with primary rat
PMNs. Direct application of up to 2  105 human PMNs onto
control OHCs had no effect on neuronal viability in the cornu
ammonis (CA1–CA3) area after 24 h (Fig. 1B). Additionally, we
investigated the effect of PMNs on neuronal function by electro-
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physiological EPSP recording with subsequent LTP induction in
1 d in vitro (DIV) hippocampal slices. This approach provides
two critical parameters of neuronal health. First, the shape and
value of the synaptic signal reflects the quantity and integrity of
the involved synapses. Second, the amount and persistence of the
synaptic potentiation represents a highly sensitive marker for
neuronal viability and functionality. According to the EPSP sig-
nal, neither the persistence nor the amount of the LTP was dis-
turbed by application of 4  105 PMNs onto the 1 DIV hip-
pocampal slices (Fig. 1C). These experiments indicated that
PMNs derived from healthy human volunteers did not cause
neuronal cell loss or neuronal electrophysiological disturbance in
rat OHCs.
PMNs exacerbate neuronal damage after
oxygen–glucose deprivation
To examine the effect of PMNs on CNS cells after ischemia, we
simulated the PMN infiltration into the brain parenchyma by
direct application of PMNs onto post-OGD OHCs (Fig. 2A).
Application of increasing numbers of PMNs onto theOHCs after
OGD resulted in a significant exacerbation of neuronal damage
compared with OGD-induced neuronal damage alone (Fig. 2B).
Representative fluorescence images of the densitometric quanti-
fication (Fig. 2B) are shown in Figure 2C. These data suggest that
PMNs can aggravate the outcome of ischemic neurological in-
sults after 24 h. For all the following experiments involving direct
application of PMNs onto OHCs, 1 105 PMNs were used.
PMNsmigrate rapidly into hippocampal slices independent
of OGD-induced neuronal damage
We had previously shown that microglia can migrate deeply into
OGD-damaged OHCs to provide neuroprotection (Neumann et
al., 2006). Thus, we speculated that also PMNs might immigrate
into OHCs, albeit with a neurotoxic effect after OGD. To test this
assumption directly, we subjected cocultures of OGD-treated
OHCs and PMNs to two-photon microscopy as previously de-
scribed (Neumann et al., 2006). In this model, OHCs are made
from mice that express EYFP under a specific Thy-1 promoter
that leads to strong expression of the transgene in hippocampal
neurons (Feng et al., 2000). We observed the rapid migration of
PMNs into the brain tissue after 1 h under basal conditions.
However, the PMN immigration rate into OGD-damaged slices
was indistinguishable from that observed under control condi-
tions (Fig. 3A,B). Also, at later time points, we detected a uni-
form distribution of PMNs within the slice and no differences
between OGD conditions and basal conditions were observed
(Fig. 3A–F). Additionally, we studied the morphology of EYFP-
positive neurons within the OHCs after PMN application. The
application of PMNs onto hippocampal slices without OGD
showed morphologically intact neurons (neuronal body, den-
drites, axons) at all analyzed time points (Fig. 3A,C,E). In con-
trast, OGD slices containing PMNswere characterized by a severe
loss of axons and dendrites after 6 h (Fig. 3D) and an almost
complete loss of EYFP-positive neurons associated with the ap-
pearance of subcellular granular material, presumably stemming
Figure 1. PMNs infiltrate the brain parenchyma 1 d after in vivo focal ischemia.A1, Hematoxylin/eosin staining of a coronal section shows an ischemic lesion in the cortex 1 d after focal ischemia.
A2, Higher magnification from the edge of the ischemic lesion shows polymorphonuclear cells pointed by black arrows. A3, The black box in A2 is enlarged in A3 and demonstrates the occurrence
of PMNs shown by the polymorph nucleus. Scale bar: A1, 200m; A2, 20m; A3, 10m. B, A total of 2 10 5 PMNs was applied in 1l onto untreated OHCs. Quantification of neuronal death
in CA1–3was determinedby PI incorporation after 24 h [control (CTRL) vs PMNs, nonsignificant (n.s.);n 9/bar]. In the panel next to the bar chart are representative PI fluorescent images showing
neuronal death in CA1–3 after 24 h. C, Because of the nearly twice greater surface of 25-d-old slices, we applied 4 10 5 PMNs in 2l onto 1 DIV slices. The recording shows that applied PMNs did
not influence EPSP signal nor the amount and persistence of LTP (CTRL vs PMNs, n.s.; CTRL 11; PMNs, n 6). Analogous traces represent typical recordings of single experiments taken 10 min
before tetanization and 60 min after tetanization. Error bars indicate SEM.
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from neuronal apoptosis and necrosis, in the CA1 area after 24 h
(Fig. 3F). We also noted the appearance of holes in the otherwise
homogenous layer of intact neuronal somata (Fig. 3F, arrow-
heads), which probably showed the loss of cell bodies in the re-
spective areas. Thus, although PMNs have the ability to invade
OHCs under normal conditions, they do not cause neuronal
damage, unless this process is initiated by OGD.
Exogenous microglia counteract the neurotoxicity of PMNs
We previously showed that microglia can have a neuroprotective
function in the OGD-induced neuronal damage within OHCs
(Neumann et al., 2006). We next asked whether this might also
hold true for the PMN-induced neurotoxicity. The direct appli-
cation of PMNs (Fig. 4A), microglia, or macrophages
(RAW264.7) to control OHCs had no effect on neuronal viability
in the CA area after 48 h (Fig. 4B,C). However, although the
presence of PMNs in OGD-treated OHCs showed a strong exac-
erbation of OGD-induced neuronal damage after 24 and 48 h
(Fig. 4B,C), microglia application resulted in a significant reduc-
tion of OGD-induced neuronal damage after 48 h but not after
24 h (Fig. 4B,C). No significant effect on neuronal death was
observed after application of macrophages (Fig. 4B,C). We
next wanted to analyze whether microglia were also able to
counteract the massive neurotoxicity induced by PMNs.
Therefore, we applied PMNs (1  10 5) in combination with
microglia or macrophages (0.8  10 5 each) directly onto the
OHCs (Fig. 4D). The combined application of PMNs and
microglia resulted in a significant reduction of PMN-caused
exacerbation of neuronal damage after OGD (Fig. 4E). In con-
trast, no significant effect was detected by simultaneous appli-
cation of PMNs and macrophages. These data suggested that
there might be a direct interaction between microglia and
PMNs, which significantly attenuated the deleterious effects of
PMNs on neuronal survival.
Figure 2. Polymorphonuclear granulocytes (PMNs) exacerbate neuronal damage after OGD.A, Different numbers of PMNs (0.5 10 5, 1 10 5, 2 10 5) were applied onto OHCs after OGD.B,
Quantification of neuronal death in CA1–3was determined by PI incorporation after 24 h (***p 0.001 vs OGD; n 7/bar). Error bars indicate SEM. CTRL, Control. C, Representative PI fluorescent
images showing neuronal death in CA1–3 after 24 h.
Figure 3. The migration of PMNs into the OHCs under basal and OGD conditions. PMNs (1  10 5) were labeled with CMTMR (red) and then directly applied onto OHCs prepared from
B6.Cg-TgN(Thy1-YFP)16Jrsmice (neurons: green). At indicated time points (basal, 1, 6, 24 h; OGD, 1, 6, 24 h), sliceswere fixedwith 4%PFA and subsequently Z-stacks through thewhole OHCswere
performed by using two-photonmicroscopy. A–F, Images show three-dimensional reconstruction of the OHCs and the representative focal plane (middle of OHCs) in the CA1 neuronal layer at the
indicated time points after PMN application under basal conditions (A, C, E) or after OGD (B, D, F ). Scale bars, 20m.
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Microglia engulf PMNs within the OHCs
Based on these findings, we investigated a possible direct micro-
glia–PMN interaction in OGD-damaged OHCs. Therefore, we
applied fluorescently labeled PMNs and microglia onto the
OHCs. Confocal microscopy analyses revealed that exogenous
microglia had engulfed PMNs in OGD-treated OHCs (Fig. 5A).
By means of two-photon microscopy and three-dimensional re-
construction of individual microglia, we found that endogenous
as well as newly applied microglia were able to fully incorporate
single or multiple PMNs within the OHCs (Fig. 5B).To investi-
gate the cellular dynamics of such an engulfing process in more
detail, we applied fluorescently labeled PMNs andmicroglia onto
OHCs and recorded their migratory behavior by time-lapse mi-
croscopy. Surprisingly, we observed that, in addition to inactive
(immotile and presumably apoptotic) PMNs, microglia were
able to also engulf active (motile and viable) PMNs (Fig. 5C;
supplemental movie 1, available at www.jneurosci.org as supple-
mental material).
Microglia engulf viable, motile, nonapoptotic PMNs
The previous experiments suggested that the microglia was able
to engulf fully viable PMNs. However, although the phagocytosis
of apoptotic cellularmaterial bymicroglia is a relatively common
process (Stolzing and Grune, 2004; Takahashi et al., 2005; Chan
et al., 2006), the capture of active and viable cells bymicroglia has
not been observed before. Phototoxicity and bleaching prevented
us from performing hour-long time-lapse sequences on individ-
ual OHCs. However, in several instances, we were able to docu-
ment the uptake of live PMNs by parenchymal microglia within
the brain slices in a manner very similar to the one observed
before for isolated microglia (supplemental movie 6, available at
www.jneurosci.org as supplemental material), which suggests
that the behavior of the externally addedmicroglia was similar to
the parenchymal cells. The related low frequency of phagocytosis
events in individual image sequences did not allow performing a
thorough quantitative analysis of PMN phagocytosis in this ex
vivo model system. We therefore performed cell culture experi-
ments in vitro. PMNs (3  105) were cocultured with primary
microglia (0.75  105) in vitro. These experiments allowed to
clearly visualize the engulfing process ofmotile PMNs by individ-
ual microglia (Fig. 6A,B) and demonstrated that before being
engulfed and phagocytosed PMNs could exhibit profoundmotil-
ity over long time periods (Fig. 6A,A*).
We frequently observed that microglia adopted a “chasing
behavior” while attempting to engulf PMNs, either including cel-
lular protrusions (supplemental movie 2, available at www.
jneurosci.org as supplemental material) or the whole cell bodies
(Fig. 6B; supplemental movie 3, available at www.jneurosci.org
as supplemental material). Because also immotile (presumably
apoptotic or preapoptotic) PMNs were engulfed by microglia
Figure 4. Exogenousmicroglia counteract PMN neurotoxicity. In A–C, the effects of PMNs, microglia, andmacrophages (RAW264.7) were examined individually. A, PMNs (1 10 5), microglia
(0.8 10 5), andmacrophages (0.8 10 5) were applied directly onto the OHCs after OGD. B, Quantification of neuronal death in CA1–3was determined by PI incorporation after 24 and 48 h (24
h: ***p 0.01 vs PMNs; 48 h: ***p 0.001 PMNs vs OGD, **p 0.01MIC vs OGD; n 9/bar). C, Representative PI fluorescent images showing neuronal death in CA1–3 48 h after OGD. InD–F,
the effect of combined application of PMNs/microglia or PMNs/RAW264.7 was studied. D, PMNs were applied directly onto the OHCs together with microglia or macrophages after OGD. E,
Quantification of neuronal death in CA1–3 was determined by PI incorporation after 24 h (***p 0.001 PMNs vs PMNs/MIC; n 9/bar). Error bars indicate SEM. F, Representative PI fluorescent
images showing neuronal death in CA1–3 24 h after OGD. MIC, Microglia; RAW, RAW264.7.
5970 • J. Neurosci., June 4, 2008 • 28(23):5965–5975 Neumann et al. •Microglia Protect against PMN Toxicity
(Fig. 6B; supplemental movie 4, available at www.jneurosci.org
as supplemental material), we next addressed the question of
whether engulfed PMNs always exhibited signs of proapoptosis.
Therefore, we transferred PMNs to primary microglia and added
FITC-labeled Annexin V to the coculture. Annexin V binds to
phosphatidylserine on the outer side of the membrane of cells
that have already initiated the apoptotic cascade (Fadok et al.,
1992). Thus, in our coculture system, proapoptotic cells (espe-
cially PMNs)were detectable by an increased FITC signal (Fig. 7).
This set of experiments revealed that microglia indeed engulfed
both proapoptotic PMNs and healthy PMNs (Fig. 7; supplemen-
tal movie 5, available at www.jneurosci.org as supplemental ma-
terial). Our experimental setup required a 48 h resting period of
primary microglia before use. Attempts to apply microglia di-
rectly shaken from the culture were not successful because these
cells were not very active and partially died during the first hour
of investigation. Thus, it could not be excluded that microglia
were activated by the necessary culture conditions. Microscopic
analysis of the cells showed that untreated microglia were very
adhesive to plastic but, in the presence of supernatant of OGD-
treated OHC or PMNs, detached from the plastic surface and
obtained a motile morphology (supplemental Fig. 1, available at
www.jneurosci.org as supplemental material), which suggested,
that indeed the microglia was activated by
the presence of PMNs or the supernatant
of OGD-treated OHC. Thus, it was possi-
ble that the observed phagocytosis behav-
ior was a general phenomenon of activated
macrophage-like cells and not specific for
microglia. To test this assumption, we
compared the ability of primary microglia
with peritoneal macrophages freshly iso-
lated from rats by peritoneal lavage with
PBS. Analysis showed that despite being
motile and frequently touching or drag-
ging PMNs in the culture peritoneal mac-
rophages never engulfed PMNs, whether
apoptotic or alive (supplemental movie 7,
available at www.jneurosci.org as supple-
mental material), whereas microglia
cocultured in the same experiment phago-
cytosed on average 2.6 PMNs per cell (sup-
plemental Fig. 2 and movie 8, available at
www.jneurosci.org as supplemental mate-
rial). Thus, the ability to phagocytose live
or dead PMNs seemed to be specific for
microglia activated by the presence of
PMNs or the supernatant of OGD-treated
OHC and was not observed with periph-
eral macrophages, at least from the
peritoneum.
Blocking the engulfment process of
PMNs bymicroglia worsens the
outcome of neuronal viability
after OGD
Next, we investigated whether the engulf-
ment of PMNs by microglia had any con-
sequence on neuronal viability after OGD.
It has been shown that apoptotic PMN
cells can be internalized by binding to the
v3-integrin receptor on macrophages.
In addition, lectin-like receptors have been
shown to be involved in this process (Fadok et al., 1998;Meszaros
et al., 1999). Thus, we evaluated the potential of the integrin-
blocking tetrapeptide RGDS (Arg-Gly-Asp-Ser) and the lectin
inhibitor N-acetyl glucosamine (GlcNAc) to block the engulfing
process by preincubating primary microglia with the reagents
before adding PMNs to the culture. We distinguished between
engulfment of motile or immotile PMNs by time-lapse micros-
copy. RGDS and GlcNAc blocked the engulfing of both immotile
and, interestingly, also motile PMNs, highly significantly (Fig.
8A). Thereby GlcNAc was more efficient than RGDS (Fig. 8A).
We also noted a slight synergistic effect on the blockade of the
engulfment process when both substances were combined. This
synergistic effect was more pronounced in the engulfment of
nonmotile cells (Fig. 8A). Additionally, we always observed al-
tered microglia–PMN interaction patterns in the presence of
RGDS and GlcNAc.Whereas untreatedmicroglia bound and en-
gulfed PMNs, treated microglia bound several PMNs but mostly
failed to ingest them (Fig. 8B).
An important question was whether interfering with the en-
gulfment process affected the neuronal viability after OGD. To
test this, we applied PMNs andmicroglia simultaneously onto the
OHCs after OGD. Microglia and OHCs were also preincubated
with RGDS/GlcNAc before application. Indeed, the presence of
Figure 5. Microglia phagocytose PMNs within the OHCs. PMNs (1 10 5) were labeled with CMFDA (green) (A, B) or CMAC
(blue) (C) andmicroglia with CMTMR (red) and then directly applied onto OHCs. A, OHCwas fixed with 4% PFA and subsequently
investigated using confocal microscopy. B, The images from a living slice show the three-dimensional reconstruction of one
microglia that had already phagocytosed two PMNs (arrows) and was in progress to phagocytose another PMN (asterisk). The
dotted line indicates the contact between microglia and PMNs. C, Time-lapse video microscopy was performed 4 h after experi-
mental onset. Images show the engulfing of amotile PMNby themicroglia. Thewhite line indicates themigration pathway of the
PMN. Themicroglia contacted the PMN at the time (3min after start of time-lapse imaging) at which the PMN showed a velocity
of 7.6m/min. The white dotted line shows the contact point between microglia and PMN (supplemental movie 1, available at
www.jneurosci.org as supplemental material). Scale bars: A, 20m; B, 5m; C, 10m.
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RGDS or GlcNAc alone, and, more effi-
ciently, in combination strongly reduced
the neuroprotective function of coapplied
microglia in this model (Fig. 8C). In addi-
tion, we obtained similar results by using
primary rat PMNs, confirming that the
observed behavior was specific for PMNs
(Fig. 8C).
Thus, blocking the engulfment of
PMNs bymicroglia severely compromised
the neuroprotective function that micro-
glia exerted on neurons on OGD exposure
pointing to a physiological role of this cel-
lular function of microglia.
Discussion
This study was designed to determine the
role of individual cell types of the innate
immune system that contribute to the
postischemic inflammation after cerebral
ischemia. Taking advantage of our neu-
roinflammation model, we were able to
simulate the migration and infiltration of
these cells to the site of damage in the neu-
ronal tissue. It is generally accepted that
the main immune cells involved in the
inflammation-induced secondary neuro-
nal damage are PMNs, microglia, and
macrophages, which all are recruited as
early as the postischemic inflammation is
initiated. However, PMNs and local mi-
croglia are the first cells present on site,
followed by peripheral microglia and
monocytes/macrophages. Although all
three cell types potentially exhibit cytotox-
icity by releasing noxious substances such
as cytokines, oxygen radicals, and proteases (Hallenbeck et al.,
1986; Barone et al., 1991; Minghetti and Levi, 1998), their indi-
vidual contribution for the overall damage remains unclear.
There is still an ongoing debate as to the importance of the
individual cell types in brain ischemia. In an attempt to overcome
this limitation, we chose to use a well established ex vivomodel of
neuroinflammation (Ullrich et al., 2001;Mitrasinovic et al., 2005;
Neumann et al., 2006). Using this model, we were now able to
demonstrate that indeed only PMNs sharply increased neuronal
damage associatedwith transient ischemia. Thiswas not a general
phenomenon of infiltrating phagocytes, because neither local nor
externally addedmicroglia normacrophages appeared to be neu-
rotoxic after cerebral ischemia. In fact, we and others previously
showed that local (Kohl et al., 2003) or externally added (Neu-
mann et al., 2006) microglia may even be neuroprotective in this
model. Our data provide strong evidence that PMNs are a critical
innate immune cell type that is responsible for the increase of
neuronal damage associated with ischemia. This finding is well in
linewith previous studies showing enhancedneuronal death after
ischemia in a dissociated neuronal culture (Dinkel et al., 2004).
Moreover, in vivo studies strongly correlate the degree of PMN
infiltration to the size of the neuronal damage (Beray-Berthat et
al., 2003b; Weston et al., 2007). Another study found a positive
correlation between the intensity of myeloperoxidase staining, a
hallmark of PMN activity, and the degree of neuronal damage in
the area of ischemia (Matsuo et al., 1994). This finding also
strongly supports the view that PMNs are critically involved in
the progress of postischemic neuronal damage.
Interestingly, the inhibition of reactive oxygen species (ROS)
productionbyNAD(P)H-oxidases, one of the key actions of inflam-
matoryPMNs (Segal, 2005), results in strongneuroprotective effects
in rodentmodels of ischemic stroke (Wang et al., 2006; L. L. Tang et
al., 2007).Moreover, interferingwith thehomingof immunecells by
an antiadhesive therapy has been shown to be neuroprotective
(Connolly et al., 1996; Yanaka et al., 1996). However, because this
approach affects indiscriminately all immune cell types, it did not
provide any suggestions as to whether PMNs might play a specific
role in this context. In addition, it is assumed that also cells of the
adaptive immune systemcan invade areas of ischemia-inducedneu-
roinflammation (Arumugam et al., 2005). Because their contribu-
tion is still unclear, ourmodel iswell suited to examine thismatter in
the future. In summary, in the line of these previous data and our
study, it seems likely that PMNs constitute an important neurotoxic
cell type under ischemic conditions. Because we did not find evi-
dence thatmicroglia andmacrophageswere neurotoxic, at least 48 h
after ischemia,weassumethat interferingwith the functionofPMNs
might be a particularly promising option to limit the extent of neu-
ronal damage after stroke.
A major conclusion from our study is that there seems to be a
naturalmechanism aiming precisely at this goal. After coapplying
microglia and PMNs onto ischemically damaged OHCs, we
found a strong decrease of neuronal damage compared with the
application of PMNs alone. This was a rather unexpected finding,
because numerous studies demonstrated that microglia preacti-
Figure 6. Microglia engulf motile PMNs. The panels show CMFDA (green)-labeled PMNs (3 10 5) cocultured with primary
microglia (0.75 10 5). Cellmovementswere recorded by time-lapsemicroscopy.A, The panel displays amicroglia that engulfed
amotile CMFDA-labeled PMN (arrow).A*, The image depicts the PMNmigration path (white line) before themicroglia contacted
and engulfed the PMN (red circle). The integrated white graph shows the PMN velocity of 5m/min at the time the microglia
had touched the PMN (supplemental movie 2, available at www.jneurosci.org as supplemental material). B, Images show the
engulfment of an immotile CMFDA-labeled PMN (arrow) (supplemental movie 4, available at www.jneurosci.org as
supplemental material). Scale bars, 10m.
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vated by inflammatorymediators are strongly neurotoxic (Arai et
al., 2004; Minghetti et al., 2004; Qin et al., 2004; Fordyce et al.,
2005; Huang et al., 2005). However, a close inspection of these
studies shows thatmicroglial activationwas achieved by exposure
tomicrobial products (Arai et al., 2004; Qin et al., 2004; Huang et
al., 2005) or viral particles (Lim et al., 2003; Minghetti et al.,
2004). Lipopolysaccharide (LPS) or viral particles are well known
to trigger a massive immune cell reaction via Toll-like receptors
(TLRs) (Kawai and Akira, 2006). Recent evidence suggests that,
even in the situation of stroke, which constitutes a sterile inflam-
mation, Toll-like mediated pathways can be triggered on micro-
glia (Lehnardt et al., 2007) or even directly onneurons (S. C. Tang
et al., 2007) and that this response increases neuronal damage after
stroke. However, the signaling induced by
bacterial TLR triggersmightwell bedifferent
from the one induced by endogenous in-
flammatory mediators because neurons,
which express both TLR-2 and -4 do not re-
spond to classical triggers of these receptors
such as peptidoglycan or LPS (S. C. Tang et
al., 2007). It might, therefore, be possible
that alsomicroglia are able to distinguish be-
tween microbial and other inflammatory
stimuli of the TLR system. In this concept,
microglia activated by nonmicrobial inflam-
mation might exert neuroprotective effects,
whereas microbial activation of microglia
preferentially triggers neurotoxicity.
Our study also provides insights into the
mechanism whereby this protection is ac-
complished.We demonstrate thatmicroglia
were very effective in phagocytosing invad-
ing PMNs. Macrophage-like cells are well
known to clear the inflamed tissue from cell
debris, such as apoptotic PMNs. Two recent
histological studies have also demonstrated
brain-resident microglia associated with
PMN-related debris in areas of ischemia-
induced neuronal damage (Denes et al.,
2007; Weston et al., 2007). However, our
data show that, in addition to proapoptotic
PMNs, also fully viable,AnnexinV-negative,
PMNs were effectively engulfed by
microglia.
In contrast, we have never observed mi-
croglia engulfingother typesof immunecells
such as freshly prepared lymphocytes and
monocytes, and in addition we did not find
engulfing of PMNs by macrophage lines or
freshly prepared peritoneal macrophages.
These findings underscore the specificity of
the microglia–PMN engagement. By time-
lapsemicroscopy,we observedmicroglia ex-
erting a PMN chasing behavior, either in-
cluding cellular protrusions or thewhole cell
bodies. To the best of our knowledge, the
phagocytosis of active and viable immune
cells by other immune cells has not been de-
scribed so far and therefore might represent
an entirely novel way of immune control.
This is probably attributable to the fact that
such a mechanism can only be revealed by
life cell imaging, which is technically chal-
lenging, especially with the cell types investigated in the current
study.
Given the fact that phagocytosis was inhibitable by RGDS
peptides and GlcNAc, we assumed that integrins such as vitro-
nectin receptors (Ruoslahti, 1996) or lectinsmediated the engulf-
ment process. Although this is well known for the uptake of ap-
optotic cells (Fadok et al., 1998; Meszaros et al., 1999), this
surprisingly also held true for the uptake of presumably live cells.
We cannot formally exclude that even Annexin V-negative cells
were already proapoptotic thereby exposing vitronectin or lectin
ligands. However, the fact that the cells were very motile argued
against this hypothesis, because one of the earliest events of apo-
ptosis is loss of migration (Savill et al., 2002).
Figure 7. Microglia engulf preapoptotic and nonapoptotic PMNs. FITC-conjugated Annexin V was added to the microglia–
PMN coculture, and thus proapoptotic cellswere visualized by an increased FITC signal. Thewhite thin arrowpoints on anAnnexin
V-positive PMN that was fully engulfed after 12 min. The arrowhead shows a PMN that was engulfed without exhibiting a FITC
signal at any time point of the engulfment process (supplemental movie 5, available at www.jneurosci.org as supplemental
material). Scale bars, 10m.
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Our study also indicates that interference with the phagocytosis
process by RGDS and GlcNAc abolished the neuroprotective func-
tion of microglia. It is well conceivable that dying PMNs mediate
neurotoxicityby the releaseof toxic intracellular compounds (Denes
et al., 2007; Weston et al., 2007), and that, consequently, prompt
phagocytosis of apoptotic PMNs by microglia might prevent the
secretion of toxic compounds. In the light of these findings, we pro-
pose that clearance of PMNs from the nervous tissue might be an
effective strategy to protect neurons from PMN neurotoxicity.
Whether the engulfment of viable PMNs contributes to this protec-
tion remains to be determined and requires to be examined in addi-
tional studies. In our system, phagocytosis of motile (presumably
viable) PMNswas evenmore frequent than the uptake of nonmotile
cells. Therefore, it appears unlikely that this process is irrelevant for
the protectionwe observed.Howmicroglia turn off the neurotoxic-
ity of a live PMN currently remains enigmatic. A possible mecha-
nism might include active interference with cytokine secretion and
productionofROS.Thismightbemediatedby the rapiddestruction
of engulfed PMNs, which appears to be happening to PMNs after
phagocytosis by microglia in our system. Finally, it has also been
shown thatmacrophages release immune-regulatory cytokines such
as TGF- (Savill et al., 2002) after uptake of apoptotic PMNs. A
similar process might also be exhibited by microglia after uptake of
PMNs, with TGF- mediating neuroprotection by reducing the
general inflammatory responses. Future studies are required to ver-
ify whether the processes observed in our ex vivo model are truly
active and physiologically relevant in vivo. If so, future therapies
might aim achieving neuroprotection by
supporting microglia activation, thereby
rapidly eliminating infiltrating PMNs from
the ischemic lesion site.
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bstract
To address the scientific quest for unravelling signalling pathways crucial in CNS development and function, cell culture systems have to be
eveloped that are mimicking the physiological state of brain cells more efficiently. Here, we describe a method for cultivation of a virtual three-
imensional structure consisting of neural stem cell-derived cell types by using Matrigel as surface substrate and Start V as a serum free medium.
e demonstrate that free floating dissociated cells form attached neurospheres from which cells start migration to surrounding areas and develop a
irtual three-dimensional cell structure composed of neurons, glia and neural stem cells. Neuronal precursor cells differentiate into cholinergic and
ABAergic cells and express vesicle proteins. Further, neuronal cells are interwoven with Nestin positive stem cells and GFAP positive astrocytes.
dditionally, oligodendrocytes and microglia can also be detected in this neural tissue-like structure. As an example for studying cell migration
e added externally microglial cells (BV2) and performed a confocal time lapse study. It revealed, that co-cultivated microglial cells migrated
owards neurospheres within 14 h. Thus, the described method provides a serum free, tissue-like primary cell culture system of neural cells useful
or the investigations of basic cell–cell interactions under in vitro conditions.
2006 Elsevier B.V. All rights reserved.
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. Introduction
Primary cultures consisting of dissociated neurons or astro-
ytes prepared from hippocampal or cortical tissue present
idely used in vitro models for neurophysiological and neu-
opharmacological applications. The various research areas
nclude protein expression studies of receptor-proteins (Brown
t al., 1997), axonogenesis (Dotti and Banker, 1987; Mandell
nd Banker, 1998; Hayashi et al., 2002; Oliva et al., 2003), sig-
alling pathways (Grewal et al., 2000), intraneuronal transport
henomenons (Davis et al., 1987) and toxicity studies (Keilhoff
nd Erdo, 1991). The feasibility of cultivation of dissociated
euronal cells prepared from embryonic rats was firstly demon-
trated by Banker and Cowan (1977, 1979). At the beginning
eurons were co-cultivated with tissue explants. Then, feeder
ell layer were developed as a crucial nutrient source for the sur-
ival of cultivated neurons (Dichter, 1978). Later, co-cultivation
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E-mail address: Holger.Braun@ifn-magdeburg.de (H. Braun).
i
a
(
p
e
t
c
165-0270/$ – see front matter © 2006 Elsevier B.V. All rights reserved.
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as withdrawn and replaced by either serum free media or
edia supplemented with serum (Xie et al., 2000; Romijn,
988; Brewer, 1995). However, since dissociated cell cultures
f hippocampal or cortical origin are composed of neurons and
lial cells, strongly proliferating astrocytes will displace non-
roliferating neurons. To impede this, cytostatic drugs, as for
xample AraC (cytosine arabinoside) were added to growing
ells (Hertz et al., 1982, 1989; Waagepetersen et al., 1998).
Primary cultures offer the opportunity for visualizing many
rocesses like axonogenesis or synaptogenesis on the level of
ingle cells. Immunocytochemical methods are frequently used
or this purpose. For applying modern immunofluorescent meth-
ds it is inevitable to grow the cells on glass cover slips to
revent quenching or autofluorescence effects. Therefore, coat-
ng the cover slips is needed for successful cell attachment
nd growth. Various compounds, as for example poly-l-lysine
PLL), laminin or poly-l-ornithine are described for coating
rocedures (Kondratyev et al., 1989; Pons et al., 2001; Rubin
t al., 2002). Here, we describe the cultivation of primary cor-
ical neural cells isolated from embryonic rats on cover slips
oated with the extracellular matrix Matrigel. Cells were grown
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nder serum free conditions using the neuronal differentiation
edium Start V without adding any cytostatics. Matrigel is
solubilized basement membrane preparation extracted from
he Engelbreth–Holm–Swarm (EHS) mouse sarcoma and con-
isting of laminin, collagen IV, heparan sulfate, proteoglycans,
ntactin and nidogen (Kleinman et al., 1982). After polymeri-
ation at room temperature Matrigel produces a biologically
ctive matrix resembling the extracellular matrix produced by
ammalian cells. Start V Medium was especially designed
or culturing of neuronal cells without adding serum. Here,
e report that Matrigel and Start V Medium allow a quick
nd easy preparation of primary cultures from neural tissues.
e demonstrate that initially dispersed single cells form neu-
ospheres which give rise to a virtual three-dimensional cell
tructure composed of neurons, astrocytes and oligodendrocytes
s well as neural stem cells and microglia. Furthermore, as an
xample for studying cell–cell contacts we demonstrate the inter-
ction of microglial cells added from outside with our primary
ulture.
. Material and methods
.1. Cell culture
Male and female rats were paired for 3 days. Positive vagi-
al plaque test was dated as day E0. On day E18 the pregnant
emale was deeply anesthetised by chloroform and decapitated.
he uteri were dissected from the abdomen and transferred to a
terile petri dish with ice cold PBS. Embryos were removed
nd immediately decapitated. The skulls were collected into
ce cold Hanks-buffer (Biochrom; Berlin, Germany) and can be
tored on ice for at least 1 h without harmful effect on later cell
ulture.
Embryonic brains were removed from the skull by per-
orming a longitudinal incision and subsequent removal of
he brain from the skull using tweezers. Both hemispheres of
he cortex were removed from the remaining brain stem and
ransferred into DMEM (Dulbecco’s Modified Eagle Medium;
iochrom) with 10% FBS (Biochrom). Cortical tissue from 6
nimals was mechanically dissected by using 5 ml pipettes and
ubsequently Pasteur pipettes. Tissue pieces were centrifuged
320 × g for 2 min) and resuspended in Hanks-buffer without
a2+ and Mg2+ (Biochrom). For further removing of bivalent
etal ions, 1 ml EDTA/PBS (1%, w/v; Biochrom) was added.
fter centrifugation, brain tissue was resuspended again in 6 ml
anks-buffer and 2 ml Trypsin/EDTA solution (0.25%/0.02%,
iochrom) was added. Trypsinisation of cells was performed
nder gentle agitation for 2–3 min at room temperature and
eaction was stopped by adding of 4 ml DMEM with 10%
BS. After centrifugation the proteolytically digested tissue
as resuspended in DMEM with 10% FBS and squirted twice
hrough a syringe equipped with a 23 gauge needle. Follow-
ng final centrifugation cells were resuspended in DMEM with
0% FBS and counted using a Neubauer hemicytometer. After-
ards, 1.3 × 106 cells/well (2 ml/well) were seeded on Matrigel
Becton Dickinson, Heidelberg, Germany) coated glass cover
lips.
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Coating the cover slips with Matrigel was performed accord-
ng to suggestions of the manufacturer. Cells need only a thin
ayer of polymerized Matrigel. Best polymerisation and best
ell grow is achieved by coating the cover slips with undiluted
atrigel. However, this is very cost-intensive and acceptable
ell grow also occurs by diluting the Matrigel 1:35 with ice cold
ulture media, e.g. DMEM. For that, Matrigel has to be thawed
n advance on ice. The best way to do this is transferring the vial
ith Matrigel directly from −20 ◦C into ice and keeping the box
ith ice at 4–7 ◦C overnight.
It is important to pipette the Matrigel rapidly, since poly-
erization can already happen in the tip of the pipette. Once
he Matrigel is diluted it should be stored on ice. The diluted
atrigel is dropped onto the cover slips (calculate 500l for
0 mm cover slips). Culture plates with coated cover slips were
hen stored in the cell culture incubator for at least 15 min (longer
ncubation times even over few hours are not problematic). The
atrigel-containing media was removed immediately before
eeding the cells. Matrigel stock solution can be refreezed sev-
ral times.
Cells were grown under standard conditions, i.e. 37 ◦C and
% CO2. DMEM with 10% FBS was changed by 1 ml Start V
edium (Biochrom) 24 h later. After 48 h 1 ml Start V Medium
er well (6 well plate) was added additionally. Starting from
hat point medium was changed every 48 h by fresh Start V
edium.
.2. Immunocytochemistry
Cortical primary cultures were fixed for at least 10 min
y 4% paraformaldehyde. After washing in PBS and block-
ng with 10% donkey serum (Sigma, Deisenhofen, Germany),
rimary antibodies were applied overnight at room tempera-
ure in PBS containing 1% donkey serum. Cells were anal-
sed by immunocytochemistry using following antibodies:
onoclonal mouse antibodies to neuronal nuclear antigen
NeuN, 1:200, Chemicon, Temecula, CA, USA), glial fibril-
ary acidic protein (GFAP, 1:200, Chemicon), nestin (1:200,
D Transduction Laboratories, San Jose, CA, USA), III tubu-
in (1:1000, Promega, Mannheim, Germany), CNPase (1:1000,
bcam, Cambridge, UK), GABA (1:500, Sigma), Ox 42 (1:200,
erotec, Du¨sseldorf, Germany) and SV2 (1:200, Develop-
ental Hybridoma Bank, Iowa City, IA, USA), polyclonal
oat antibodies to DCX (1:300, Santa Cruz Biotechnology,
anta Cruz, CA, USA), and choline acetyltransferase (ChAT,
:100, Chemicon) and polyclonal rabbit antibodies to glutamate
ecarboxylase (GAD65/67, 1:500, Sigma) and NG2 (1:300,
hemicon).
Primary antibodies were visualized by Cy2 or Cy3 conju-
ated secondary antibodies, e.g. donkey anti-mouse, donkey
nti-goat and donkey anti-rabbit (1:500, Dianova, Hamburg,
ermany) for 2 h at room temperature. Nuclei were counter-
tained by DAPI (1:15,000, Mobitec, Go¨ttingen, Germany). To
how antibody specificity, cells were stained by secondary anti-
odies only. Adhered cells were dehydrated by increasing con-
entrations of ethanol (50–100%), briefly submerged in xylol
nd mounted in DPX (Fluka, Buchs, Switzerland).
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Confocal analysis was performed using a LSM 5 Pascal laser-
canning microscope (Zeiss, Jena, Germany) and Axiovision
.05 software (Zeiss).
.3. Culture of microglia cell-line BV2
The BV2 microglia was cultured in DMEM supplemented
ith 10% FBS, 1% Pen/Strep (Biochrom), 1% l-Glutamin
Biochrom) at a density not exceeding 5 × 105 cells/ml and
aintained in 5% CO2 at 37 ◦C. To harvest BV2 microglia, cells
ere trypsinated (Trypsin/EDTA), then centrifuged (500 × g for
min) and resuspended in Neurobasal Medium (Gibco, Eggen-
tein, Germany). Cell concentration was determined by counting
ells in a Neubauer hemicytometer and viability was assessed
y trypan blue staining (0.4% trypan blue in PBS, Sigma). BV2
icroglia was added to 10 day old cortical primary cultures in
n effector-to-target cell (E/T) ratio of 0.3/1. Viability of sup-
lemented BV2 microglia was confirmed by prior staining with
TO (Invitrogen, Karlsruhe, Germany).
.4. Time-lapse imaging by confocal laserscannig
icroscopy
BV2 microglia was labelled with 10M CTO and added to
IV10 aged cortical culture prepared from transgenic B6.Cg-
gN (Thy1-YFP) 16Jrs mice (green fluorescent neurons). This
ouse strain was created by The Jackson Laboratory (USA) andurchased from Charles River (Sulzfeld, Germany). Imaging
as performed by using a confocal laserscanning microscope
Zeiss LSM 510 Meta under control of axiovision software
nd a 20× Neofluar air lens, NA 0.5). Images were recorded
i
t
a
b
ig. 1. Phase contrast pictures of a cortical primary culture. (A) 50 min after seeding
igration of neural precursors from neurospheres into the surrounding area 2 days af
ar: 100m.nce Methods 157 (2006) 32–38
very 45–60 s, reading the red and green channel simultaneously.
maging was performed over 14 h permanently at the same spot
ithout obvious bleaching or inhibition of cell motility.
. Results and discussion
We prepared primary cortical neurons from E18 rat embryos
nd cultivated them on Matrigel coated glass cover slips and
tart V Medium. Under these conditions dissociated and ini-
ially free floating cells start to aggregate and form neurospheres
ttached to the surface of cover slips (Fig. 1A and B). After
emoving serum, as a result of changing DMEM medium to
tart V Medium, cells start to migrate from these neurospheres
nd form a network of neuronal cells (Fig. 1C and D). As
eported by others, we also found that addition of serum dur-
ng the first 24 h increases the survival and proliferation of
euronal cells (Leemhuis et al., 2004). However, if cells are
ontinuously cultured in serum, the continuous proliferation of
stroglial cells leads to suppression of neuronal cells (Xie et al.,
000).
Neurospheres, developing shortly after seeding of dissoci-
ted cells, are composed mainly of neuroblasts double-labelled
y DCX and III tubulin (Fig. 2A). Both markers are also
xpressed in processes originating from neurospheres (Fig. 2B).
hese processes are used by cells for migration into surrounding
reas (Fig. 1B and C). Immunostaining of DCX and III tubulin
evealed the complex structure of a neuronal network develop-
ng over a period of 5–7 days of culturing. It has to be mentioned
hat the density of this network varies inside of one well. Even
t culture day 7 regions with lower and higher cell density can
e identified (Fig. 2D and E).
of dissociated cells. (B) 22 h after seeding neurospheres have been formed. (C)
ter seeding. (D) After 7 days a dense network of neuronal cells is formed. Scale
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Fig. 2. Confocal analysis of immunocytochemical stained cultures. Cultures were fixed either 2 days after seeding (A–C) or 7 days after seeding (D–L). (A–E) DCX
(red) and III tubulin (green) positive neurospheres. A network of different densities is formed between neurospheres (C–E). Few of the DCX positive neurons
(red) in the network are co-labelled with NeuN (green, F). (G) Nestin positive stem cells appear in different morphologies and sizes. (H) Many neurons are positive
for the vesicle marker SV2 indicating the existence of synapses. (I and J) Nestin processes are interwoven with DCX and III tubulin processes. But there is no
c ) and
b ) The
i colou
m
z
(
2
i
l
t
b
eo-localization between DCX (red) and Nestin (green, I) as well as Nestin (red
eneath the neuronal network consisting of III tubulin positive cells (green). (L
n all pictures except B and G (100m). (For interpretation of the references to
DCX is described in vivo to be a marker for young, mainly
igrating neuroblasts found exclusively in the subventricular
one (SVZ) of the lateral ventricle and in the subgranular zone
SGZ) of the dentate gyrus (Brown et al., 2003; Rao and Shetty,
004). In our primary culture system DCX can be detected even
n an established network of neuronal cells (Fig. 2E). Time
apse videos demonstrated that in areas with high cell densi-
D
S
n
iIII tubulin (green, J). (K) Nestin positive cells (red) are often found located
expression of GFAP demonstrates the presence of astrocytes. Scale bar: 50m
r in this figure legend, the reader is referred to the web version of the article.)
ies as shown in Figs. 1D and 2E only little cell movement can
e observed (not shown). Nevertheless DCX is still abundantly
xpressed in neurons located in these areas. This suggests that
CX might be expressed in vivo in regions outside of SVZ and
GZ but that the level of expression in more mature neurons is
ot sufficient for detection by immunohistochemistry. Interest-
ngly, DCX positive neurons can be co-labelled with NeuN, a
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lassical marker for mature neurons (Fig. 2F). This observation
s in line with other in vivo findings, detecting also DCX posi-
ive cells outside of the SVZ, and about 8% of these obviously
igrating neurons were double-labelled with NeuN (Yang et
l., 2004). The functional maturation of the neuronal network is
urther supported by expression of SV2, a protein specifically
xpressed on synaptic vesicles (Fig. 2H).
Non-neuronal cells are difficult to identify by phase-contrast
icroscopy. However, immunocytochemistry revealed the exis-
ence of both GFAP positive astroglia (Fig. 2L) and nestin posi-
ive neural stem cells (Fig. 2G). Nestin cells are found in different
izes and morphology, but mainly these stem cells are either
f flattened morphology located beneath the neuronal network
Fig. 2K) or rounded and elongated cells that are interwoven with
euronal cells (Fig. 2I and J). Besides nestin positive cells are
lso present in just formed neurospheres (not shown). Interest-
ngly, we did not find any co-expression of nestin positive cells
ith DCX or III tubulin markers (Fig. 2I–K), indicating an
brupt down-regulation of nestin expression when neural stem
ells start to differentiate into neurons.
After 7 days of cultivation neuronal cells contain sub-
opulations of neurons as for example cholinergic (Fig. 3A)
nd GABAergic neurons (Fig. 3B and C). Finally, we were
nterested in the existence of oligodendrocytes and microglia
nd indeed, both cell populations were present. Immunostain-
ng with antibodies recognizing oligodendrocytic marker pro-
eins NG2 (Fig. 3D) and CNPase (Fig. 3E) revealed cells with
ypical oligodendrocytic morphology. Ox 42, an antibody rec-
gnizing the cell surface marker CD11b/c present on microglia
nd macrophages, discovered the presence of microglial cells
a
n
1
ig. 3. Confocal imaging of 7 days old cortical primary cultures. (A–C) Neurons of dif
nd markers for GABAergic neurons illustrated by immunostaining against GABA (
recursor cells were identified by NG2 (D) and CNPase (E) expression. (F) Microglia
xcept C (50m).nce Methods 157 (2006) 32–38
xhibiting a morphology of very large and flattened cells
Fig. 3F). The occurrence of microglia in primary cultures was
rst demonstrated by Jordan and Thomas (1987).
Matrigel promotes differentiation and migration of many cell
ypes by providing a three-dimensional substrate for cell growth
Grant et al., 1985; Hadley et al., 1985; Kubota et al., 1988) and
upported in vivo peripheral nerve regeneration (Madison et al.,
985). Further, it was demonstrated, that regulator proteins of
roliferation like sonic hedgehog (SHH) directly interact with
eparan sulfate proteoglycans and laminin (Pons et al., 2001;
ubin et al., 2002). Both proteoglycan components are part of
he Matrigel composition. Therefore, Matrigel coating creates
uch more optimal conditions for cell growth than coating with
aminin or other substrates alone. In fact, both phase contrast
nd confocal laserscanning microscopy clearly demonstrated
he three-dimensional structure composing of neuronal and glial
ells as well as stem cells and microglia. Thus, the primary cell
ulture of cortical cells described here should be considered as
neural tissue-like structure arised from dispersed cells rather
han being a simple mixture of dissociated cells. By using Start
Medium we were able to grow this culture for at least 3 weeks
nder serum free conditions and without the usage of inhibitors
or mitosis like AraC.
In order to evaluate the usefulness of such a culture for the
nvestigation of cell–cell contacts, we added fluorescent labelled
V2 cells to a 10 day old primary culture prepared from trans-
enic B6.Cg-TgN (Thy1-YFP)16Jrs mice embryos. Migratory
ctivity of CTO-labelled microglial cells (BV2) invading into
eurospheres was analysed by time lapse confocal imaging over
4 h (Fig. 4).
ferent subtypes could be detected by expression of choline acetyltransferase (A)
B) and Glutamate decarboxylase (GAD65/67, C). (D and E) Oligodendrocytic
cells were detected by Ox42 immunostaining. Scale bar: 30m in all pictures
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Fig. 4. Migration of microglia into neurospheres of cortical primary cultures. BV2 microglia were labeled with CTO (red) and then added directly to cortical primary
cultures prepared from transgenic B6.Cg-TgN (Thy1-YFP)16Jrs mice (neurons: green). Co-cultures were recorded by time-lapse confocal laserscanning microscopy.
(A) Begin of recording 1 h after application of BV2 microglia. White circle indicates the extension of the neurosphere. (B) End of recording 14 h after application. (C)
14 h after application Z-stacks of neurospheres were performed. Image shows BV2 microglia inside the neurosphere. (D) The white line indicates the representative
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Gigration pathway of a microglial cell over a time frame of 13 h. Scale bar: 50
eader is referred to the web version of the article.)
An artificial tissue-like culture prepared in the way described
n this paper will have several advantages and disadvantages
ompared to organotypic slice cultures (Chechneva et al., 2005).
he latter more preserve the cellular architecture while the
rimary culture is easier to handle and single cells are more
usceptible to various kinds of investigation. Taken together,
atrigel and Start V Medium can be applied for the rapid estab-
ishment of a serum free, tissue-like primary culture of cortical
ells useful for studying effects of growth factors, expression
atterns of marker proteins, synapse formation and functions as
ell as cell–cell interactions under in vitro conditions.
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The Power of Single and Multibeam Two-Photon Microscopy for
High-Resolution and High-Speed Deep Tissue and Intravital Imaging
Raluca Niesner,*y Volker Andresen,z Jens Neumann,§ Heinrich Spiecker,z and Matthias Gunzer*
*Helmholtz Centre for Infection Research, Junior Research Group Immunodynamics, D-38124 Braunschweig, Germany; yInstitute of
Physical and Theoretical Chemistry, Technical University of Braunschweig, D-38106 Braunschweig, Germany; zLaVision Biotec GmbH,
33607 Bielefeld, Germany; and §Institute for Applied Neuroscience, 39120 Magdeburg, Germany
ABSTRACT Two-photonmicroscopy is indispensable for deep tissue and intravital imaging. However, current technology based
on single-beam point scanning has reached sensitivity and speed limits because higher performance requires higher laser power
leading to sample degradation. We utilize a multifocal scanhead splitting a laser beam into a line of 64 foci, allowing sample
illumination in real time at full laser power. This technology requires charge-coupled device ﬁeld detection in contrast to
conventional detection by photomultipliers. A comparison of the optical performance of both setups shows functional equivalence
in every measurable parameter down to penetration depths of 200 mm, where most actual experiments are executed. The
advantage of photomultiplier detectionmaterializes at imaging depths.300mmbecause of their better signal/noise ratio, whereas
only charge-coupled devices allow real-time detection of rapid processes (here blood ﬂow). We also ﬁnd that the point-spread
function of both devices strongly dependson tissue constitution andpenetration depth.However, employment of a depth-corrected
point-spread function allows three-dimensional deconvolution of deep-tissue data up to an image quality resembling surface
detection.
INTRODUCTION
Fluorescence microscopy is an important tool in biomedical
research for the study of tissues, cells, and even subcellular
structures with high spatial and temporal resolution (1). As a
result, the dynamics of live cells form the focus of many
approaches. To avoid alterations induced by isolation from
their natural environment, observing cellular behavior in
living animals has become the preferred method for these
analyses (2). The possibility of investigating cells in their
natural environment is considered to be crucial for under-
standing their functions and behavior (2–4). Conventional
wide-field or confocal intravital fluorescence microscopy can
be applied to investigate blood flow in superficial vessels (3)
or the migration of cells in subcapsular zones of peripheral
lymph nodes (5). Often, however, the biologically most
interesting phenomena such as T-cell activation happen 100–
400 mm below the surface of relevant tissues in mice. The
excitation wavelengths typically used in confocal microscopy
hardly allow the examination of cells this deep in living tissue
or whole animals. As a result of significant scattering and
absorption occurring in optically dense samples, only a few
times 10 mm can be investigated at the microscopic level.
Therefore, cutting the object into slices is often the only
method to obtain information about cell dynamics inside
(6,7).
The invention of multiphoton microscopy (MPM) (8)
represents a breakthrough in tissue and intravital studies. It
substantially enlarges the penetration depth to a couple of
hundred micrometers, thus enabling noninvasive imaging
with subcellular resolution in intact animals (9). In addition to
its larger penetration depth, MPM provides inherent optical
sectioning, reduced photobleaching and photodamage out-
side the focal plane, and convenient excitation of UV-
absorption bands of intrinsic fluorophors (7). Despite its
subcellular resolution, MPM is also able to record simulta-
neous activity of multiple neurons in vivo by means of field
detection of calcium currents (10). Although it has been
widely used in neurology since its introduction more than 15
years ago (8), only in the last 5 years have immunologists also
‘‘discovered’’ MPM for their questions. Since then a huge
number of publications (recently reviewed (4,9,11,12)) found
multiple novel insights into the biophysics of cell migration
and cell-cell communication under different conditions. Thus,
given the obvious success of the technology, it can be ex-
pected that many more groups will start to set up MPM
capabilities. To this end, a very informative review has sum-
marized the advances and problems of MPM in the immu-
nology field so far (11).
The most important drawback of MPM is probably that the
two-photon-excitation efficiency of most fluorophors is very
low compared to single-photon excitation, resulting in a small
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number of emitted photons (13). This in turn leads to long
image acquisition times that are often on the order of seconds,
restricting observation of living samples and dynamic
processes within them with a high temporal resolution. A
common approach to overcome this problem is to increase the
excitation laser power to generate more fluorescence and use
faster scanning methods such as acousto-optical deflectors
(9,11). But because the nonlinear photo damage rises faster
than the number of excited molecules with increasing laser
power (7), crossing a critical power level does not make sense.
Thus, the only method to increase the number of fluorescence
photons per time without raising photodamage is to
parallelize the excitation process. Simultaneous excitation
with N foci results in N times more excited molecules, which
in turn enables N times quicker acquisition or much gentler
imaging.
We employ here a multiphoton scanhead that makes use of
reflecting mirrors to split an incoming infrared laser beam into
a line of up to 64 beamlets (14). This scanhead makes it
possible to generate up to 64 times more fluorescence light out
of a sample compared to single-beam scanning systems
without the danger of photo- or thermotoxicity. Conse-
quently, scanning can be made up to 64 times faster, allowing
real-time observation of image planes deep inside the sample
with low power in each single focus. Because this setup is
dependent on charge-coupled device (CCD)-camera field
detection, it is necessary to evaluate its optical performance.
The reference detection device here is a point detector
(photomultiplier tube, PMT), which is used by switching the
beam path inside the same scanhead to generate only a single
excitation beam. Both methods are directly compared in terms
of resolution, maximum penetration depth, and signal/noise
ratio (SNR).
Another serious problem of tissue two-photon microscopy
is the significant decrease of the optical resolution with
increasing penetration depth. Novel approaches apply point-
spread function (PSF) engineering by means of deformable
mirrors, which, however, is technically challenging (15). Our
experiments show that this is based on degradation of the
excitation PSF caused by the transit through optically dense
samples that feature a strongly varying refraction index. This
prevents the resolution of small details deeper inside the
sample. We demonstrate that the level of degradation of
the PSF is strongly dependent on the type of tissue imaged
and that application of a depth-dependent PSF for three-
dimensional deconvolution completely restores maximum
image quality.
METHODS
Multifocal two-photon microscope
All experiments were carried out using a specialized two-photon microscope
that is based on a commercial scan head (TriMScope, LaVision BioTec,
Bielefeld, Germany, Supplementary Fig. 1). We used either CCD cameras or
photomultipliers for detection (14).
Agarose ﬁlms
A 4% (wt %) aqueous suspension of agarose (Merck, Darmstadt, Germany)
was boiled and then mixed with a 0.002% suspension of fluorescent
polystyrene beads (emission maximum 440 nm and 515 nm, Invitrogen,
Karlsruhe, Germany). The volume ratio of the suspensions was 7:3. The
still-fluid mixture was quickly pipetted onto a glass slide and cooled down to
room temperature to solidify.
Preparation of lymph nodes
A total of 25 ml of a 2% suspension of green fluorescent polystyrene beads
was injected into the footpad of 8-week-old BALB/c mice (Harlan,
Germany). Overnight, the beads moved into the popliteal lymph nodes.
Mice were sacrificed, and the lymph nodes were isolated and used for
experiments concerned with the analysis of spatial resolution.
Preparation of brain slices
Organotypic hippocampal brain slices (OHBS) were prepared as described
(30) from 10-day-old transgenic B6.Cg-TgN (Thy1-YFP)16Jrs mice
(Jackson, distributed by Charles River, Wilmington, MA), which express
EYFP at high levels in subsets of neurons, including the pyramidal cells of
the hippocampus (31). Hippocampi were dissected and transversely sliced
into a 500-mm or a 700-mm thickness on a McIlwain tissue chopper (The
Mickle Laboratory Engineering, Surrey, UK). OHBS were immediately
fixed with 4% PFA for 40 min at room temperature and were maintained
in 30% sucrose. OHBS were then cryosectioned to suitable thickness as
described (30). Before usage, OHBS were rinsed in phosphate-buffered
saline (PBS) for 3 3 10 min.
To determine the ePSF in OHBS, we kept 100 ml of a suspension of
fluorescent beads (as used above within agarose) on each side of OHBS for
3–4 h at 37C. This 100 ml of suspension was obtained by diluting a 2 wt %
stock suspension of beads 1:1000 with water and adding 15 vol % DMSO.
Under these conditions we could not observe any damage to the morphology
of the samples. After the incubation with bead suspension, the OHBS were
washed so that no bead clusters remained on the sample surface.
Intravital microscopy
Mice were prepared for intravital microscopy using Isofluran-based
intubation narcosis and gentle exposure of the inguinal lymph node as
described (5). Blood-flow measurements were performed on blood vessels
above the inguinal lymph node. For blood staining, anesthetized mice were
injected i.v. with 100 ml Rhodamine-6G (1.25 mM in 0.9% NaCl). Subse-
quently, spleen cells stained with CFSE (5 mM) or CTO (5 mM) were also
injected i.v. Imaging was performed until 1h after injection, when the
Rhodamine signal was beginning to decay.
The animal experiments were approved by the Gewerbeaufsichtsamt
Braunschweig under file number 509.42502/07-04.04 and were performed
in accordance with current guidelines and regulations.
RESULTS
For single-beam imaging, PMTs were used to detect the
fluorescence, whereas in multibeam mode CCD cameras were
employed. Consequently, the comparison between these two
different methods is also a comparison of the optical per-
formance between a pixel-by-pixel and a field-detection
device.
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Calibration and benchmarking of the
measurement system
The optical performance of an imaging system for biological
tissues is defined by its maximum spatial (lateral and axial)
resolution, the maximum penetration depth, and the depth-
dependent signal/noise ratio (ddSNR). Thus, we first inves-
tigated these parameters using an agarose gel as a model for a
homogeneous sample.
The spatial resolution of a laser-scanning microscope is
determined by the dimensions of the effective (detected)
point-spread function (ePSF) of a punctiform object with
dimensions below the resolution limit. The rigorous math-
ematical description of the PSF is complicated (16–19). A
commonly accepted procedure is to approximate the two-
photon ePSF by simpler three-dimensional peak functions
such as the two-dimensional Gauss-Lorentz distribution or
the asymmetrical three-dimensional Gauss distribution (16).
Indeed, the experimental ePSFs measured with our setup
could be fitted by asymmetrical three-dimensional Gauss
functions. The ePSFs were measured by collecting the local
three-dimensional fluorescence signal of small labeled
polystyrene beads whose diameter (100 nm) was below the
resolution limit of our setup.
To characterize the resolution of the single-beam PMT
compared to the multibeam CCD setup, we performed ePSF
measurements with both methods in thick agarose gels. This
was done at different excitation wavelengths in the range of
720–920 nm, with two different types of labeled beads
(fluorescence maximum at 440 and 515 nm), at different
penetration depths, and with two different lenses, i.e., a 203
high-working-distance water-immersion objective (NA ¼
0.95) and a 1003 low-working-distance oil-immersion
objective (NA ¼ 1.4). The lateral and axial dimensions of
the ePSFs were determined from one-dimensional Gaussian
fits of the respective x, y, and z profiles. Thereby, we con-
sidered the maximum extension of the ePSF in each direction
for evaluation.
In conformity with the diffraction theory (16), both the
lateral and the axial resolution decreased with increasing
excitation wavelength, whereas neither the emission wave-
length nor the penetration depth had a measurable effect on
the spatial resolution (Supplementary Table 1).
The dimensions of the theoretical PSF, calculated using
paraxial approximation, corresponded very well to the spatial
resolution measured in agarose. At an excitation wavelength
of 800 nm, the calculated axial resolution was 347 nm, and the
lateral resolution 1.47mm, whereas the measured values were
(lateral) 344 6 14 nm and (axial) 1.41 6 0.09 mm, re-
spectively (Fig. 1, A and B).
The maximum penetration depth in agarose measured
using the 203 objective was larger than 900 mm, i.e., the
thickness of the sample, for both setups. The spatial resolution
in this depth measured using green fluorescent beads (fluo-
rescence maximum at 515 nm) excited at 780 nm amounted to
364 6 12 nm (lateral) and 1.42 6 0.02 mm (axial) for the
multibeam CCD setup and to 3636 16 nm (lateral) and 1.446
0.07 mm (axial) for the single-beam PMT setup. Thus, in
agarose the loss of resolution caused by imaging depth was
less than 2.5%.
The spatial resolution measured with a high-NA objective
in agarose at 780-nm excitation wavelength (fluorescence
maximum 515 nm) was 207 6 7 nm (lateral) and 814 6 31
nm (axial) for the multibeam CCD setup and 209 6 10 nm
(lateral) and 817 6 16 nm (axial) for the single-beam PMT
setup. These values correspond to already published results
using the same or similar lenses (20,21). The maximum
penetration depth was limited to 100 mm by the working
distance of the objective.
Despite its very high spatial resolution, the 1003
objective is inadequate for imaging biological samples
because of its short working distance and the need for oil
immersion. Thus, all further experiments were performed
with the more appropriate 203 water-immersion objective.
For directly comparing the spatial resolution of the single-
and multibeam excitation mode, we used the CCD camera as
detector for both modes to rule out differences introduced by
the detection method. We performed ePSF measurements in
agarose using 3-mW laser power in the focus of each beam
and 12-ms pixel time. Independent of the number of laser
beams (1, 2, . . . 64) used, all experiments yielded the same
axial and lateral resolution. By using the 203 objective
combined with a twofold magnification of the fluorescence
image, a pixel resolution of 161 nm on the CCD chip and of
141 nm on the reconstructed PMT image was obtained. For
the 1003 objective, the pixel resolution was 65 nm on the
CCD chip and 56 nm on the PMT image. The steps between
two consecutive optical slices were adjusted to 300 nm in all
ePSF measurements.
Spatial resolution decreases with imaging depth
and sample complexity
Transparent media such as agarose are advantageous for
characterization of the maximum optical performance of
imaging devices. However, there are large differences be-
tween this ideal model and genuine probes. To test the
influence of optical density and refraction-index variation, we
performed ePSF experiments on two tissue types of particular
interest, i.e., OHBS and lymph nodes. Fig. 1,C andD, depicts
representative results for depth-dependent ePSFs in OHBS,
whereas E and F show typical values in the lymph node. The
xy region considered for evaluation was relatively small (153
15 mm2) because the heterogeneous surface (nonplanar in the
range of several micrometers), which is typical for brain slices
and lymph nodes, affects penetration depth and resolution.
Only when one is measuring small xy regions is the imaging
depth nearly uniform over the whole image.
The spatial resolution in biological samples was strongly
influenced not only by the penetration depth but also by the
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tissue constitution, which varied strongly even within the same
sample (Figs. 1 and 2). To quantify this effect, we compara-
tively measured the dependence of the spatial resolution on the
penetration depth in lymph nodes and OHBS in regions con-
taining either mainly axons or somata. Representative results
are depicted in Fig. 2. Importantly, the decrease in resolution
was independent of the detection device. Laser powers of 3
mW/beam were used in all ePSF experiments within biological
FIGURE 1 Dependence of the spatial (lateral and axial) resolution on the penetration depth measured in (A and B) agarose, (C and D) brain tissue, and (E and F)
lymph nodes with both the single-beam PMT and the multibeam CCD setup. Typical lateral and axial profiles of experimental ePSF are shown in three different
depths for (G) agarose, (H) brain tissue, and (I) lymph node. The ePSF were measured using green fluorescent beads (emission maximum 515 nm) excited at
800 nm. Each value of the spatial resolution was calculated as the average over 6–15 data points.
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samples, no matter which detection method was used. The pixel
time for CCD-based measurements ranged between 12 and
21 ms, whereas that for PMT measurements was between 70
and 160 ms/pixel. Thus, the PMT images were acquired
by scanning significantly more slowly to collect enough signal
per pixel.
Deconvolution with depth-dependent ePSF
Mathematical postprocessing of fluorescence images leads to
a considerable gain of information and optical quality. One of
the most efficient techniques is the three-dimensional decon-
volution of raw data, i.e., z-stacks of fluorescence images,
with corresponding PSFs (22). Currently, three-dimensional
deconvolution is performed using a constant PSF either
calculated from the technical data of the microscope or
evaluated from the fluorescence three-dimensional signal of a
punctiform object, usually measured in an ideal sample such
as agarose. However, we observed that the PSF was not a
constant parameter but rather was strongly influenced by the
constitution of the sample and by the penetration depth
(Fig. 2). This insight gave rise to the question of whether a
three-dimensional deconvolution performed with a depth-
dependent PSF typical for the imaged sample would lead to an
improvement of the postprocessed data as compared to the
currently used three-dimensional deconvolution techniques.
Thus, we imaged a region of a 78-mm-thick OHBS that
was fixed between two coverslips, from both sides. In this
way, we collected two mirrored three-dimensional stacks of
the same region, so that the first image (Fig. 3 F) at the
surface of one stack corresponded to the last image (Fig. 3 C),
i.e., deepest layer, of the other. This allowed imaging the
same region within a biological tissue either through 75 mm
of overlying tissue (the usual approach in deep tissue in vivo
imaging) or directly from the other side. Thus, we could also
produce the same picture without any tissue layer disturbing
the image, giving the optimal result obtainable within this
sample. Moreover, we measured the depth-dependent ePSF
in both three-dimensional stacks, so that for each fluores-
cence image the corresponding ePSF was known (Fig. 3,
A–C, F). The ePSF used for deconvolution was averaged
within each xy plane but was specifically taken in each
z-position.
As expected, increasing penetration depth degraded both
the resolution and the optical quality of the fluorescence
images (Fig. 3, A–C). Even if images C and F in Fig. 3 show
the same OHBS area, because of scattering, the quality of
image C collected through 75 mm of tissue is considerably
lower than that of image F, which was collected through only
3 mm of tissue from the opposite side of the sample.
By three-dimensional deconvolution based on the ePSF
measured in agarose, which corresponded to the calculated
PSF, the amount of detail was not evidently larger than that
in the original image (Fig. 3, C and D), although the noise
increased dramatically (Fig. 3, D and G). Three-dimensional
deconvolution based on the penetration depth-dependent
ePSF of brain tissue delivered an even higher optical quality
than the direct image of the same area, which was collected
through only 3 mm of tissue (Fig. 3, E and F). Thus,
postprocessing using the depth-corrected PSF can generate
images from planes deep inside tissue with a resolution
comparable to that obtained by imaging near the surface.
FIGURE 2 Dependence of the spa-
tial resolution on the penetration depth
in lymph nodes and in brain slice
regions containing axons and somata,
respectively. The ePSF experiments
were performed with green fluorescent
beads (emission maximum 515 nm)
using the multibeam CCD setup at 800
nm excitation wavelength. Images
show representative pictures of brain
slices from Thy-1-EYFP transgenic
animals or lymph nodes from wt ani-
mals where red and green leukocytes
had been adoptively transferred before
imaging. Please note the abundance of
cell bodies in lymph nodes (either from
transferred red or green cells or from
endogenous autofluorescent cells) and
brain regions with somata, whereas
axon-rich brain areas display a rela-
tively low number of (black, i.e.,
EYFP-negative) cell bodies.
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Maximum penetration depth and SNR
Many relevant biological phenomena happen at a consider-
able depth within highly scattering biological tissues. Thus,
the maximum penetration depth at which useful dynamic,
high-resolution images can still be generated is a central
feature of tissue imaging devices.
Thus, we measured the maximum penetration depth in
OHBS, both with the multibeam CCD and with the single-
beam PMT setup. The maximum penetration depth reached
;500 mm for the single-beam PMT setup and ;300 mm for
the multibeam CCD setup. Consequently, the fluorescence
signal strongly decreased with increasing penetration depth
independent of the detection device. However, this decrease
was more rapid for the multibeam CCD than for the single-
beam PMT system (Fig. 4 A).
It is evident that the maximum penetration depth is
reached when the fluorescence signal decreases to the level
of the background noise and, thus, cannot be distinguished
from it any more. The parameter that defines the relation
between the fluorescence signal and the background noise
is the SNR, which in maximum penetration depth reaches
the value 1 (SNR ¼ 1) by definition.
With the multibeam CCD setup, the SNR value of 1 was
reached at 310 mm depth, whereas with the single-beam
PMT setup this happened at 510 mm depth (Fig. 4 B). It is
noteworthy that down to a penetration depth of;150 mm the
SNR values were similar for both setups, and the reduction
of the SNR was moderate; i.e., the SNR decreased 45% in
both systems within the first 150 mm of penetration into the
sample. Loss of SNR was accelerated at higher depths. In the
FIGURE 3 Deconvolution with depth-
dependent ePSF allows restoration of
images from deep tissue layers to the
quality level of surface data. Fluores-
cence images of a 78-mm-thick brain
slice and corresponding xz cross sections
of the in situ measured ePSF: (A) at the
surface, (B) in 37 mm depth, and (C) in
75 mm depth. (D) Three-dimensional
deconvolved image of C using the ePSF
measured at the surface (identical to the
ePSF measured in agarose). (E) Three-
dimensional deconvolution of C using
the ePSF measured in 75-mm depth. (F)
The same layer as C but imaged from the
other side of the brain slice, i.e., through a
brain tissue layer of only 3 mm thickness.
The diagrams G, H, I, and J represent
intensity profiles along a line through the
two bright spots indicated by red arrows
in the images C–F. For optimal decon-
volution, the heights of maxima as well
as height of the minimum have to be as
close as possible to the ‘‘perfect’’ image
in F. The experiments were performed
using the multibeam CCD setup at an
excitation wavelength of 800 nm. The z-
step between two consecutive optical
slices was 500 nm.
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range 150–300 mm depth, 96% of the SNR was lost with
CCD and only 71% with PMT detection (Fig. 4 B). This was
the main reason for the higher penetration depth of the PMT
detection method. Consequently, within depths of 150–200
mm, CCD and PMT performed equally well. As a result,
images obtained from both devices in this region show a
comparable degree of optical content and resolution (Fig. 4
C). Fluorescence images of a 166-mm-thick sample of a brain
slice obtained with the single-beam PMT setup appeared only
slightly crisper (Fig. 4 C).
A laser power of 2 mW/beam was chosen for all SNR
experiments. The pixel time used for CCD-based imaging
was 6 ms/pixel (pixel size 322.5 3 322.5 nm2), and that for
single-beam excitation with a PMT as detector amounted to
5 ms/pixel (pixel size 293 3 293 nm2). The scanned sample
region was 300 3 300 mm2 in both cases.
Imaging speed
Thus, the main advantage of the single-beam PMT setup
over the multibeam CCD device is the larger penetration
depth in strongly scattering samples because of a better SNR
gradient (Fig. 4). However, besides imaging in deep tissue,
visualizing the dynamics of biological phenomena represents
FIGURE 4 (A) Dependence of the
fluorescence signal and of the back-
ground noise on the penetration depth
measured with the multibeam CCD or
single-beam PMT setup. Because of the
truncation of the PSF at the sample
surface, the fluorescence signal in this
depth is lower than that at 20 mm depth.
(B) Dependence of the SNR on the
penetration depth. The z-step between
two consecutive optical slices was 2 mm
(imaged region 300 3 300 mm2). (C)
Comparison between the multibeam
CCD and the single-beam PMT setup
on the example of a three-dimensional
reconstruction of an EYFP brain slice
region. A Thy-1-EYFP brain slice of 166
mm thickness was imaged either with the
multifocal CCD or the single-beam PMT
setup and subsequently voxel-rendered
with a 1-mm z-spacing. The small
images show zoomed views of two
identical regions in both stacks, reveal-
ing almost identical optical performance
and content. The excitation wavelength
was 920 nm in all experiments.
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an equally important challenge for bioimaging (11,23). In
terms of imaging speed, the multibeam CCD technique is
evidently superior to the state-of-the-art PMT method. To
obtain images of equal quality and dynamic range, a 150 3
150 mm2 area was imaged within 5000 ms with the single-
beam PMT setup and within only 83 ms with the multibeam
CCD setup. Thus, CCD detection has a clear advantage over
the single-beam PMT when high imaging speed is relevant.
A laser power of 2 mW/beam and pixel times of 0.4 ms (pixel
size 322.5 3 322.5 nm2) for the CCD and 27 ms (pixel size
293 3 293 nm2) for the PMT were used, similar to the SNR
experiments. Imaging depths between 0 and 50 mm were
taken into account.
To quantify the speed of the multibeam CCD system at the
outermost limit, we imaged the fluorescence of blood flow in
vessels of living mice two- and three-dimensionally, in one
color and in two different spectral channels, simultaneously
(Fig. 5). Although for the single-color experiments only one
CCD camera was necessary, for the dual-color experiments
fluorescence was imaged onto two synchronized CCD
cameras after being spectrally separated by a dichroic mirror.
By this approach, individual cellular and subcellular
fragments of blood (erythrocytes, white cells, and platelets)
could be visualized in almost natural (i.e., round) shape, and
many individual steps of white cells rolling on the surface of
vessels were captured (Fig. 5 A, movies 1 and 2). In rolling
cells, subcellular structures could sometimes be resolved,
making it possible to observe barrel rolling of the cell body
over the vessel surface (Fig. 5 C, movie 5).
Because the applied intravital dye Rhodamine-6G slowly
diffused out of the blood vessels, it also stained cells in the
surrounding connective tissue. Thus, this approach allowed
simultaneous visualization of the ;1003 slower autono-
mous three-dimensional movement of cells in tissue, next to
the fast transport of cells in blood vessels (Fig. 5 B, movie 3).
The two-color image sequence shows individual rolling
steps of cells in different colors separated from other cellular
blood components that were still well resolved and appeared
in yellow (Fig. 5 C, movies 5 and 6). Three-dimensional
rendering allowed reconstruction of whole cell bodies in the
free bloodstream. However, because of the fast transport,
these cells appeared distorted (Fig. 5 D, movies 3, 4, and 7).
In addition, in two-color three-dimensional experiments, we
reached the border of technical feasibility with this setup
because after spectral separation the SNR in both channels
was close to the value of 1, making it difficult to separate the
signal from background noise.
DISCUSSION
MPM of live cells in explanted tissues or living animals
today is a rapidly developing field (6). Consequently,
imaging hardware is also developing apace. In particular,
tunable Ti:Sa lasers as light source have seen an enormous
improvement from early machines, which covered a com-
plete laboratory desk and required an expert to change the
wavelength, to contemporary travel-bag-sized turn-key sys-
tems that provide a wide tuning range and easy-to-use
computer interfaces for control. Also, the output power of
these lasers has increased dramatically. Current models
provide .2 W average power at 800 nm emission, and the
most recent developments will provide as much as 2.5–3 W
including .1 W at wavelengths of .900 nm.
As a result, conventional single-beam scanheads have
built-in attenuators that decrease the laser power reaching the
sample, typically by 99%, to avoid bleaching and thermal
sample destruction. The multibeam scanhead used in this
study distributes the available laser power onto up to 64
beams, which is only 1.7% per beam. This is still enough for
efficient two-photon excitation but below the destructive
level for most applications. Consequently, the laser generally
runs at full power, and thus, much more fluorescence light
per time is generated
However, multifocal illumination requires whole-field
detection of the fluorescence with a CCD camera. Thus, it
was necessary to compare the optical performance of this
method with the usually applied PMT detection of single-
beam scanning setups. It was generally assumed that detection
with a CCD would be inferior to PMT detection because there
is no method to suppress scattered photons (11). We were,
therefore, surprised to find that neither the ePSF nor the loss of
resolution with imaging depth showed differences for both
detection devices down to imaging depths of 200 mm in
optically dense tissue. Our experiments show that the de-
velopment of the SNR is responsible for the differences in
maximum penetration depth. Although the SNR value for the
CCD decayed more rapidly than that of the PMT, it was still
well above 1 at 200 mm, where signals are lost in the
background noise. Only in very deep regions (.310mm) was
the CCD no longer able to differentiate signals, a point that
was not reached for the PMT until 500 mm imaging depth.
Because the majority of imaging studies record cellular
movements at 100–200 mm below the surface, e.g., of lymph
nodes (24–26) or the brain (27,28), our work shows that in this
area CCD detection is equivalent to PMT detection. Addi-
tionally, CCD detection will benefit from more powerful
lasers, which will enhance the SNR and thus make it possible
to reach deeper regions, although this can not be expected for
PMT because of phototoxicity issues. Because the scanhead
used here can run PMT or CCD detection, it is not necessary
to choose one system. Instead, the optimal detection device
can be used for each problem under investigation.
Our study also demonstrates that the resolution of two-
photon imaging in biological tissues is a function not only of
imaging depth but also of the environment where imaging is
performed. In brain areas where axons are predominant, loss
of resolution was much less pronounced than in areas with
high numbers of somata. The most difficult tissues studied
here were lymph nodes, which destroyed the depth-dependent
two-photon ePSF very rapidly. This argues for the concept
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that tissues with a predominance of cell nuclei, such as brain
in regions with somata but especially lymph nodes, where
.1106 nuclei are located within ;1 ml volume, are
particularly difficult for deep-tissue imaging. Thus, it was
very encouraging to find that poor-quality images from deep
regions could be deconvolved efficiently to an image quality
that can usually be obtained only directly below the surface
of tissues.
We demonstrate here that this deconvolution is possible
only if an ePSF that corresponds to the imaged tissue and,
especially, the imaged depth is used for image restoration.
Deconvolution based on a general ePSF calculated for the
optical setup produced unusable results, as already attempted
elsewhere (29). Unfortunately, currently available deconvo-
lution software does not account for depth-dependent PSF.
In addition, mathematical deconvolution is still very time
FIGURE 5 Imaging blood flow in
mice in real time with a multibeam
CCD setup. Dual-color images were
detected simultaneously with two inde-
pendent CCD cameras based on color
splitting by a 570-nm-cutoff dichroic
mirror. (A) Time projection over 11
single-color two-dimensional fluores-
cence images of a blood vessel and
surrounding tissue stained by i.v. injec-
tion of Rhodamine-6G. The time delay
between two consecutive numbers was
50 ms. Shown is a cell doublet rolling
on the surface of the vessel (white
outlines). Images were taken from
movies 1 and 2. (B) Time projection
of 11 dual-color two-dimensional fluo-
rescence images of a blood vessel
(white outlines) stained with Rhoda-
mine 6G (yellow). Spleen cells previ-
ously stained either with CFSE (green)
or CTO (red) and additionally injected
into the mouse are represented green
and red, respectively, because they
were detected by only one of the two
CCD cameras. The fact that blood cells
stained with Rhodamine-6G only ap-
pear yellow indicates their simulta-
neous detection in both cameras and
thus proves the synchronicity of the
system. The green numbers indicate the
position of a CFSE-stained cell at six
different time points, whereas the red
numbers indicate the position of a
CTO-stained cell at five subsequent
time points. The time delay between
two consecutive numbers is 50 ms.
Images were taken from movies 5 and
6. (C I) Three-dimensional visualiza-
tion of the fluorescence of a blood
vessel and surrounding tissue-resident
cells, which were stained with Rhoda-
mine 6G as described above. (C II)
Image series representing the two cells
framed in C I at six different time points
during a 180 rotation around the x
axis. The z-stacks used for the three-
dimensional representation contained
21 frames each, separated by 1 mm.
Time delay between two consecutive z-stacks was 5 s. Images were taken from movies 3 and 4. (D) Three-dimensional representations of the dual-color
fluorescence of a blood vessel in a mouse prepared as described above at three different time points. The time delay between two consecutive z-stacks was
800 ms. The z-stacks used for the three-dimensional representations contained 16 frames each, separated by 2 mm. Images were taken from movie 7. In all
experiments: minimum exposure time ¼ 28 ms, excitation wavelength ¼ 800 nm. The minimum delay between two consecutive images was limited by the
readout time of the CCD chip.
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consuming, making it difficult to reconstruct multichannel,
multistack time series. Software development to overcome
these barriers would thus be desirable. Future work needs to
show whether typical tissue-type- and depth-related ePSFs
can be obtained and used for deconvolution or whether ePSFs
must always be specifically determined for the investigated
sample. Even if this turns out to be necessary for optimal
image quality, it is not required to provide artificial sub-
resolution particles within the sample. Instead, our experience
shows that the use of small endogenous structures as a ref-
erence is possible.
Finally, we could demonstrate the potential of fast two-
photon imaging. This allowed us to visualize autonomous
movements of perivascular cells in time and space. The
identity of these cells is currently unclear. Based on their
shape and size, macrophages or lymphocytes appear likely. It
will be very interesting to see the change in migratory
behavior of these cells when a local trigger, e.g., injury or in-
fection, occurs.
However, even this setup was not able to reconstruct the
three-dimensional shape of freely flowing blood cells satis-
fyingly. This was based on reaching the technical limits. At
the given staining protocol and illumination regime, single
erythrocytes or leukocytes did simply not produce enough
fluorescence photons to allow for even shorter illumination
time, which would be the basis for more rapid z-stacks. Thus,
future developments should improve the brightness of labels.
Also higher laser power or the use of even more beams in
parallel will enable faster image acquisition times. Finally a
rapid and reliable z-stepper could be obtained by fixing the
distance between object and lens and shift the focal plane by
moving the tube lens rather than the objective. This would
avoid motion and compression artifacts and allow for rapid
z-scanning.
In summary, we have shown here that multifocal illumi-
nation opens the way to fast, yet highly accurate, two-photon
microscopy. Future developments will prove the power of
this approach for biomedical research.
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